<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64092</article-id><article-id pub-id-type="doi">10.7554/eLife.64092</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>NirD curtails the stringent response by inhibiting RelA activity in <italic>Escherichia coli</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="author-212233"><name><surname>Léger</surname><given-names>Loïc</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3641-3697</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-95133"><name><surname>Byrne</surname><given-names>Deborah</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-212234"><name><surname>Guiraud</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-212235"><name><surname>Germain</surname><given-names>Elsa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-211452"><name><surname>Maisonneuve</surname><given-names>Etienne</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3451-1223</contrib-id><email>emaisonneuve@imm.cnrs.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Laboratoire de Chimie Bactérienne, Institut de Microbiologie de la Méditerranée, CNRS-Aix Marseille Univ (UMR7283)</institution><addr-line><named-content content-type="city">Marseille</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution>Protein Expression Facility, Institut de Microbiologie de la Méditerranée, CNRS-Aix Marseille Univ</institution><addr-line><named-content content-type="city">Marseille</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Helaine</surname><given-names>Sophie</given-names></name><role>Reviewing Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Storz</surname><given-names>Gisela</given-names></name><role>Senior Editor</role><aff><institution>National Institute of Child Health and Human Development</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>29</day><month>07</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e64092</elocation-id><history><date date-type="received" iso-8601-date="2020-10-16"><day>16</day><month>10</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-07-08"><day>08</day><month>07</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Léger et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Léger et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-64092-v1.pdf"/><abstract><p>Bacteria regulate their metabolism to adapt and survive adverse conditions, in particular to stressful downshifts in nutrient availability. These shifts trigger the so-called stringent response, coordinated by the signaling molecules guanosine tetra and pentaphosphate collectively referred to as (p)ppGpp. In <italic>Escherichia coli</italic>, accumulation of theses alarmones depends on the (p)ppGpp synthetase RelA and the bifunctional (p)ppGpp synthetase/hydrolase SpoT. A tight regulation of these intracellular activities is therefore crucial to rapidly adjust the (p)ppGpp levels in response to environmental stresses but also to avoid toxic consequences of (p)ppGpp over-accumulation. In this study, we show that the small protein NirD restrains RelA-dependent accumulation of (p)ppGpp and can inhibit the stringent response in <italic>E. coli</italic>. Mechanistically, our in vivo and in vitro studies reveal that NirD directly binds the catalytic domains of RelA to balance (p)ppGpp accumulation. Finally, we show that NirD can control RelA activity by directly inhibiting the rate of (p)ppGpp synthesis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>stringent response</kwd><kwd>RelA</kwd><kwd>NirD</kwd><kwd>(p)ppGpp</kwd><kwd>bacterial stress response</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>H2020 European Research Council</institution></institution-wrap></funding-source><award-id>714934</award-id><principal-award-recipient><name><surname>Maisonneuve</surname><given-names>Etienne</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Genetic and biochemical approaches uncover a novel mode of regulation of the alarmone synthetase RelA through a functional and direct interaction with the small subunit of the nitrite reductase NirD.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Bacteria have evolved numerous molecular mechanisms to detect and cope with environmental stress, including the use of nucleotide-based signaling pathways to efficiently coordinate cellular processes and provide a fast response. Among these signaling pathways, the stringent response is a general stress response that is mediated by the accumulation of the nucleotides guanosine 5′-diphosphate 3′-diphosphate (ppGpp) and guanosine 5′-triphosphate 3′-diphosphate (pppGpp), collectively known as (p)ppGpp (<xref ref-type="bibr" rid="bib45">Potrykus and Cashel, 2008</xref>). These alarmones allow bacteria to rapidly respond and adapt to various conditions of nutritional and environmental stress by affecting gene expression and metabolism. In Gram-negative bacteria, (p)ppGpp binds RNA polymerase, thereby altering its promoter selectivity, which results in genome-wide transcriptional reprograming (<xref ref-type="bibr" rid="bib12">Durfee et al., 2008</xref>; <xref ref-type="bibr" rid="bib50">Ross et al., 2013</xref>; <xref ref-type="bibr" rid="bib51">Ross et al., 2016</xref>; <xref ref-type="bibr" rid="bib52">Sanchez-Vazquez et al., 2019</xref>; <xref ref-type="bibr" rid="bib60">Traxler et al., 2008</xref>). Additionally, (p)ppGpp also binds directly and alters the activity of several enzymes including DNA primase, translation factors, lysine decarboxylase, and polyphosphate kinase (<xref ref-type="bibr" rid="bib10">Corrigan et al., 2016</xref>; <xref ref-type="bibr" rid="bib24">Kanjee et al., 2012</xref>; <xref ref-type="bibr" rid="bib65">Wang et al., 2019a</xref>; <xref ref-type="bibr" rid="bib75">Zhang et al., 2018</xref>). Importantly, this rewiring of cell physiology also appears to play a critical role in the regulation of bacterial virulence, survival during host invasion, and antibiotic resistance and tolerance (<xref ref-type="bibr" rid="bib19">Hauryliuk et al., 2015</xref>; <xref ref-type="bibr" rid="bib20">Hengge, 2020</xref>; <xref ref-type="bibr" rid="bib22">Irving et al., 2021</xref>; <xref ref-type="bibr" rid="bib45">Potrykus and Cashel, 2008</xref>).</p><p>In <italic>Escherichia coli</italic>, (p)ppGpp synthesis and hydrolysis are regulated by RelA and SpoT, which are members of RelA/SpoT homologue (RSH) (<xref ref-type="bibr" rid="bib2">Atkinson et al., 2011</xref>) enzymes and share similar domain architecture. The enzymatic N-terminal half (NTD) has the synthetase (SYN) and the hydrolase (HYD) domains, and the C-terminal half (CTD) of the protein contains conserved domains, which play a critical role in sensing and transducing stress signals to the catalytic domains (<xref ref-type="bibr" rid="bib14">Gratani et al., 2018</xref>; <xref ref-type="bibr" rid="bib19">Hauryliuk et al., 2015</xref>; <xref ref-type="bibr" rid="bib21">Hogg et al., 2004</xref>; <xref ref-type="bibr" rid="bib34">Mechold et al., 2002</xref>; <xref ref-type="bibr" rid="bib40">Pausch et al., 2020</xref>; <xref ref-type="bibr" rid="bib58">Takada et al., 2020</xref>; <xref ref-type="bibr" rid="bib59">Tamman et al., 2020</xref>). SpoT is a bifunctional enzyme with both hydrolytic and synthetic activities while RelA is a monofunctional (p)ppGpp synthetase. Indeed, despite close sequence similarity between RelA and SpoT, RelA maintains a ‘pseudo’-hydrolase domain that is structurally conserved but enzymatically inactive. The regulation of RelA and SpoT activities represents an obvious checkpoint for (p)ppGpp levels which reveals many complexities (reviewed in <xref ref-type="bibr" rid="bib23">Irving and Corrigan, 2018</xref>; <xref ref-type="bibr" rid="bib49">Ronneau and Hallez, 2019</xref>).</p><p>Activation of the (p)ppGpp synthetase RelA occurs via a ribosomal mechanism in response to amino acid starvation or other stressful conditions, which ultimately result in amino acid starvation, for example, fatty acid starvation, that leads to lysine starvation (<xref ref-type="bibr" rid="bib18">Haseltine and Block, 1973</xref>; <xref ref-type="bibr" rid="bib56">Sinha et al., 2019</xref>). Under this condition, deacylated tRNAs accumulate and RelA interacts with uncharged tRNA at the vacant ribosomal A-site causing the activation of its (p)ppGpp synthetic activity (<xref ref-type="bibr" rid="bib1">Arenz et al., 2016</xref>; <xref ref-type="bibr" rid="bib7">Brown et al., 2016</xref>; <xref ref-type="bibr" rid="bib33">Loveland et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">Winther et al., 2018</xref>). Inversely, RelA is suggested to be inhibited by intra- and/or inter-molecular interactions under replete conditions (<xref ref-type="bibr" rid="bib15">Gropp et al., 2001</xref>; <xref ref-type="bibr" rid="bib61">Turnbull et al., 2019</xref>; <xref ref-type="bibr" rid="bib74">Yang and Ishiguro, 2001</xref>), even though it retains residual activity (<xref ref-type="bibr" rid="bib38">Murray and Bremer, 1996</xref>). Importantly, the hydrolysis function of SpoT provides an opposing activity that is crucial for balancing the basal activity of RelA. Indeed, disruption of the <italic>spoT</italic> gene results in a toxic accumulation of (p)ppGpp and is therefore lethal (<xref ref-type="bibr" rid="bib73">Xiao et al., 1991</xref>).</p><p>The regulation of SpoT activities involves sources of nutritional stress other than amino acid starvation. These include the deficiency of fatty acid (<xref ref-type="bibr" rid="bib55">Seyfzadeh et al., 1993</xref>), phosphate (<xref ref-type="bibr" rid="bib57">Spira et al., 1995</xref>), carbon (<xref ref-type="bibr" rid="bib73">Xiao et al., 1991</xref>), and iron (<xref ref-type="bibr" rid="bib64">Vinella et al., 2005</xref>). Interaction of SpoT with other factors seems to regulate the catalytic balance between the synthetic and hydrolytic activities. During fatty acid starvation, the accumulation of (p)ppGpp required a specific interaction between the acyl carrier protein and SpoT (<xref ref-type="bibr" rid="bib4">Battesti and Bouveret, 2006</xref>). Similarly, the binding of the protein YtfK with the catalytic domains of SpoT triggers (p)ppGpp accumulation during phosphate or fatty acid starvation (<xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref>). In addition, stimulation of the SpoT hydrolase activity is driven through direct interaction with the anti-σ<sup>70</sup> factor Rsd upon carbon downshift (<xref ref-type="bibr" rid="bib31">Lee et al., 2018</xref>).</p><p>Given the importance of (p)ppGpp in stress survival, virulence, and antibiotic tolerance, we have designed a genetic assay for the identification of new protein candidates that can modulate (p)ppGpp homeostasis in <italic>E. coli</italic>. We thereby discovered that overproduction of NirD, the small subunit of the nitrite reductase, decreases intracellular levels of (p)ppGpp. Importantly, our results show that overexpression of <italic>nirD</italic> limits RelA-dependent accumulation of (p)ppGpp in vivo and can prevent activation of the stringent response during amino acid starvation. Moreover, our results show that NirD is not involved in (p)ppGpp breakdown. Rather we convincingly show that, mechanistically, NirD inhibits the (p)ppGpp synthetase activity of RelA through a specific and direct interaction with the catalytic domains of RelA in vivo and in vitro.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Identification of genes counteracting the toxicity of (p)ppGpp over-accumulation mediated by RelA</title><p>At high concentrations, (p)ppGpp becomes a potent inhibitor of bacterial cell growth. Indeed, rising (p)ppGpp levels by overexpression of the <italic>relA</italic> gene has been shown to inhibit <italic>E. coli</italic> growth in amino acid-rich media (<xref ref-type="bibr" rid="bib54">Schreiber et al., 1991</xref>). To gain further insights into (p)ppGpp homeostasis, we developed a screening assay to identify genes that in multiple copies could reverse this toxicity (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). In this study, the toxic accumulation of (p)ppGpp is achieved by induction of the <italic>relA</italic> gene cloned in the low-copy-number plasmid pBbS2k under the control of the anhydrotetracycline (aTc)-inducible P<sub>tet</sub> promoter (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). <italic>E. coli</italic> MG1655 cells harboring the pBbS2k-<italic>relA</italic> were transformed with a pooled collection of plasmids obtained from the ASKA library containing almost all <italic>E. coli</italic> K-12 genes (<xref ref-type="bibr" rid="bib28">Kitagawa et al., 2005</xref>), each cloned into the high-copy-number vector pCA24N downstream of the isopropyl β-D-1-thiogalactopyranoside (IPTG)-inducible P<sub>T5-lac</sub> promoter (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). This genetic screen led us to identify 88 clones that repetitively grow on non-permissive conditions. Sequence analysis of the pCA24N derivatives from these 88 clones enabled the identification of four different genes. The <italic>spoT</italic>, <italic>gppA,</italic> and <italic>nirD</italic> genes were predominant with each one accounting for almost a third of the genes carried by the sequenced plasmids (33.0, 36.4, and 29.5%, respectively) while <italic>uhpA</italic> was only identified once (1.1%). Our observations that <italic>spoT</italic> and <italic>gppA</italic> revert toxicity associated to (p)ppGpp accumulation is consistent with previous observations (<xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Murray and Bremer, 1996</xref>; <xref ref-type="bibr" rid="bib53">Sanyal and Harinarayanan, 2020</xref>). Considering the <italic>gppA</italic> and <italic>spoT</italic> genes as internal controls of the screen, we further focused our work on <italic>nirD.</italic></p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>NirD can limit the RelA-dependent accumulation of (p)ppGpp.</title><p>(<bold>A</bold>) Schematic representation of the genetic assay using ASKA library to identify genes that in multiple copies would suppress the growth defect associated with toxic over-accumulation of (p)ppGpp. Question marks denote a putative candidate that limits RelA-dependent accumulation of (p)ppGpp. (<bold>B</bold>) NirD suppresses the growth defect associated with RelA overproduction. Wild-type <italic>E. coli</italic> MG1655 cells were co-transformed with the plasmid derivatives pBbS2k-<italic>relA</italic> and pEG25-<italic>nirD</italic> inducible by anhydrotetracycline (aTc) and isopropyl β-D-1-thiogalactopyranoside (IPTG), respectively. Serial dilutions of stationary-phase cultures were spotted on NA plates containing the indicated concentrations of inducers. Additional controls and inducer concentrations are shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>. The results are representative of three independent experiments with similar results. (<bold>C, D</bold>) In vivo (p)ppGpp dynamic in <italic>E. coli</italic> MG1655 cells carrying pBbS2k-<italic>relA</italic> and pEG25-<italic>nirD</italic> after consecutive expression of the <italic>relA</italic> and <italic>nirD</italic> genes using 100 ng/mL aTc and 1 mM IPTG, respectively. Nucleotides extracted from samples collected at the indicated times were separated by thin layer chromatography. The autoradiogram (<bold>C</bold>) is representative of three independent experiments, and the curves of the relative levels of (p)ppGpp (<bold>D</bold>) are represented as the means of the three independent experiments, the error bars depicting the SDs.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Raw autoradiogram.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-64092-fig1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Quantification of (p)ppGpp.</title><p>The amount of (p)ppGpp was normalized to total amount of G nucleotides observed in each sample. Total G is the sum of GTP and (p)ppGpp detected. The source data are provided for the relative levels of (p)ppGpp in <xref ref-type="fig" rid="fig1">Figure 1D</xref>, which are represented as the means and SDs of three independent experiments.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-64092-fig1-data2-v1.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64092-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>NirD can inhibit RelA-dependent (p)ppGpp synthesis.</title><p>(<bold>A</bold>) Growth assay of the <italic>E. coli</italic> MG1655 wild-type strain and its isogenic Δ<italic>relA spoT</italic> mutant co-transformed with the plasmid derivatives pBbS2k-<italic>relA</italic> (sd4) and pEG25-<italic>nirD</italic> inducible by anhydrotetracycline (aTc) and isopropyl β-D-1-thiogalactopyranoside (IPTG), respectively. Serial dilutions of stationary-phase cultures were spotted on NA plates containing the indicated concentrations of inducers. The results are representative of three independent experiments. (<bold>B</bold>) Growth assay of the Δ<italic>relA</italic> mutant carrying pEG25-<italic>nirD</italic> or pEG25-<italic>spoT</italic>. Serial dilutions of stationary-phase cultures were spotted on M9-glucose minimal medium plates containing the indicated concentrations of IPTG. The results are representative of three independent experiments.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64092-fig1-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>NirD balances (p)ppGpp level produced by RelA</title><p><italic>nirD</italic> encodes the small subunit of the cytoplasmic nitrite reductase (<xref ref-type="bibr" rid="bib17">Harborne et al., 1992</xref>; <xref ref-type="bibr" rid="bib41">Peakman et al., 1990a</xref>) and has never been linked to the (p)ppGpp metabolism. We first confirmed the result obtained with the high-copy-number vector pCA24N-<italic>nirD</italic> from the ASKA library by re-cloning the coding region of <italic>nirD</italic> (untagged) in a more suitable physiological plasmid harboring a tight IPTG-inducible P<sub>T5-lac</sub> promoter (pEG25). Indeed, as shown in <xref ref-type="fig" rid="fig1">Figure 1B</xref>, NirD can robustly overcome the toxicity associated to (p)ppGpp over-accumulation mediated by RelA. To further assess the role of NirD in the stringent response, we monitored (p)ppGpp levels in vivo after consecutive inductions of RelA and NirD in a double expression system assay. As shown in <xref ref-type="fig" rid="fig1">Figure 1C, D</xref>, induction of RelA is associated with a massive accumulation of (p)ppGpp, which is sharply stopped and then decreased upon NirD induction.</p><p>The rapid (p)ppGpp decay observed following NirD induction raises the possibility that NirD may trigger SpoT-dependent (p)ppGpp hydrolysis. However, NirD still suppresses toxicity associated to RelA overproduction when the double expression assay experiment is performed in a Δ<italic>relA spoT</italic> background (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). These results show that the hydrolase activity of SpoT is not involved in the reduced (p)ppGpp accumulation observed upon NirD induction. Importantly, overexpression of <italic>nirD</italic> in a Δ<italic>relA</italic> strain failed to phenocopy the well-known amino acid auxotrophic characteristic of a ppGpp<sup>0</sup> strain (Δ<italic>relA spoT</italic> mutant) (<xref ref-type="bibr" rid="bib73">Xiao et al., 1991</xref>), strongly arguing that NirD does not act as a small alarmone hydrolase (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Taken together, our results show that NirD impairs RelA-dependent (p)ppGpp synthesis in <italic>E. coli</italic>.</p></sec><sec id="s2-3"><title>NirD can prevent the stringent response in <italic>E. coli</italic></title><p>Since NirD can efficiently overcome toxicity associated to artificial level of (p)ppGpp when RelA is overproduced (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), we next address whether similar effect is observed during physiological condition known to activate RelA. In natural environment, RelA synthesizes the alarmones in response to amino acid deprivation. Indeed during amino acid starvation, deacylated tRNAs accumulate and RelA interacts with uncharged tRNA at the vacant ribosomal A-site causing the activation of its (p)ppGpp synthetic activity (<xref ref-type="bibr" rid="bib1">Arenz et al., 2016</xref>; <xref ref-type="bibr" rid="bib7">Brown et al., 2016</xref>; <xref ref-type="bibr" rid="bib33">Loveland et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">Winther et al., 2018</xref>). RelA activity is therefore required to survive under amino acid starvation, and as a result a Δ<italic>relA</italic> mutant is not able to grow in the presence of 1 mM serine, methionine, and glycine (SMG), which induces isoleucine starvation (<xref ref-type="bibr" rid="bib63">Uzan and Danchin, 1978</xref>). Interestingly, we observed that overexpression of <italic>nirD</italic> in wild-type (WT) strain phenocopies the growth defect of a Δ<italic>relA</italic> mutant on SMG plate (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), suggesting that <italic>nirD</italic> also prevents (p)ppGpp accumulation from endogenous RelA under these conditions. To further address this possibility, we monitored the dynamics of (p)ppGpp levels under amino acid starvation upon the addition of L-valine (which also induces isoleucine starvation). As shown in <xref ref-type="fig" rid="fig2">Figure 2B, C</xref>, and as previously observed (p)ppGpp rapidly increases in WT strain and reaches maximum levels within 5 min (<xref ref-type="bibr" rid="bib9">Cashel and Gallant, 1969</xref>). Remarkably, when NirD is induced prior to amino acid starvation, no significant accumulation of (p)ppGpp is detected (<xref ref-type="fig" rid="fig2">Figure 2B, C</xref>). Taken together, our results show that once induced NirD abolishes the stringent response in <italic>E. coli.</italic></p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>NirD inhibits accumulation of (p)ppGpp upon amino acid starvation.</title><p>(<bold>A</bold>) NirD inhibits cell growth on M9-glucose minimal medium supplemented with serine, methionine, and glycine (SMG). Stationary-phase cultures of wild-type <italic>E. coli</italic> MG1655 strain harboring pEG25-<italic>nirD</italic> or pEG25-<italic>spoT</italic> were spotted on NA and SMG plates containing the indicated concentrations of isopropyl β-D-1-thiogalactopyranoside (IPTG). The results are representative of three independent experiments. (<bold>B, C</bold>) Exponentially growing cells of wild-type <italic>E. coli</italic> MG1655 harboring pEG25 or pEG25-<italic>nirD</italic> were challenged for amino acid starvation by addition of 500 µg/mL of L-valine. <italic>nirD</italic> is induced by the addition of 1 mM of IPTG. Nucleotides were extracted and separated by thin layer chromatography. The autoradiogram (<bold>B</bold>) is representative of three independent experiments, and the curves of the relative levels of (p)ppGpp (<bold>C</bold>) are represented as the means of the three independent experiments, the error bars depicting the SDs.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Raw autoradiogram.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-64092-fig2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Quantification of (p)ppGpp.</title><p>The amount of (p)ppGpp was normalized to total amount of G nucleotides observed in each sample. Total G is the sum of GTP and (p)ppGpp detected. The source data are provided for the relative levels of (p)ppGpp in <xref ref-type="fig" rid="fig2">Figure 2C</xref>, which are represented as the means and SDs of three independent experiments.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig2-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64092-fig2-v1.tif"/></fig></sec><sec id="s2-4"><title>NirD functionally interacts with RelA in vivo</title><p>Regulation of RSH activities through protein–protein interactions has been previously reported (<xref ref-type="bibr" rid="bib4">Battesti and Bouveret, 2006</xref>; <xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref>; <xref ref-type="bibr" rid="bib16">Hahn et al., 2015</xref>; <xref ref-type="bibr" rid="bib26">Karstens et al., 2014</xref>; <xref ref-type="bibr" rid="bib29">Krüger et al., 2020</xref>; <xref ref-type="bibr" rid="bib31">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Peterson et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Raskin et al., 2007</xref>; <xref ref-type="bibr" rid="bib47">Ronneau et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Ronneau et al., 2019</xref>; <xref ref-type="bibr" rid="bib72">Wout et al., 2004</xref>). We therefore tested whether NirD is able to interact with RelA in vivo using a bacterial two-hybrid (BTH) assay (<xref ref-type="bibr" rid="bib25">Karimova et al., 1998</xref>). For that purpose, the complementary T18 and T25 domains of <italic>Bordetella pertussis</italic> adenylate cyclase (CyA) were fused to the N-terminus of NirD and RelA proteins using the two compatible vectors pUT18C and pKT25, respectively. When the <italic>E. coli</italic> BTH101 strain (<italic>cya</italic> deficient) is co-transformed with plasmids harboring T18 and T25 fusions, NirD exhibited a strong interaction in vivo with RelA (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). However, despite the strong sequence homologies between the paralogous RelA and SpoT proteins (<xref ref-type="bibr" rid="bib35">Metzger et al., 1989</xref>), no physical interaction is observed between SpoT and NirD in vivo by BTH assay (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). This result therefore supports a strong specificity of the interaction between NirD and RelA.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>NirD can inhibit RelA-dependent accumulation through physical interaction in vivo.</title><p>(<bold>A</bold>) Bacterial two-hybrid assay using <italic>E. coli</italic> BTH101 cells co-transformed with plasmid derivatives pKT25-<italic>relA</italic> or pKT25-<italic>spoT</italic> and pUT18C-<italic>nirD</italic> or pUT18C-<italic>nirD<sup>E50K</sup></italic>. Stationary-phase cultures were spotted on NA plates containing X-Gal as a blue color reporter for positive interaction. The bars showing β-galactosidase activity are represented as the means of three independent experiments, and the error bars depict the SDs. (<bold>B</bold>) Growth assay of <italic>E. coli</italic> MG1655 cells co-transformed with the plasmid derivatives pBbS2k-<italic>relA</italic> and pEG25-<italic>nirD</italic> or pEG25-<italic>nirD<sup>E50K</sup></italic> inducible by anhydrotetracycline (aTc) and isopropyl β-D-1-thiogalactopyranoside (IPTG), respectively. Serial dilutions of stationary-phase cultures were spotted on NA plates containing the indicated concentrations of inducers. The results are representative of three independent experiments. (<bold>C, D</bold>) In vivo (p)ppGpp level dynamic in <italic>E. coli</italic> MG1655 cells carrying pBbS2k-<italic>relA</italic> and pEG25-<italic>nirD</italic> or pEG25-<italic>nirD<sup>E50K</sup></italic> after successive inductions of expression of the <italic>relA</italic> and <italic>nirD</italic> or <italic>nirD<sup>E50K</sup></italic> genes using 100 ng/mL aTc and 1 mM IPTG, respectively. Nucleotides extracted from samples collected at the indicated times were separated by thin layer chromatography. The autoradiogram (<bold>C</bold>) is representative of three independent experiments, and the curves of the relative levels of (p)ppGpp (<bold>D</bold>) are represented as the means of the three independent experiments, the error bars depicting the SDs. (<bold>E</bold>) Growth curves of wild-type (WT) cells, Δ<italic>nirD,</italic> and <italic>nirD<sup>E50K</sup></italic> mutants under anaerobiosis in M9-glucose minimal medium without amino acids (left panel) or supplemented with 1 mM serine, methionine, and glycine (SMG) (right panel) (see Materials and methods). The growth curves are representative of at least three independent experiments, and the Δ(lag phase) are represented as the means (± SD) of the independent experiments.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Determination of β-galactosidase activity.</title><p>The relative β-galactosidase activity was calculated as follows:<inline-formula><mml:math id="inf1"><mml:mn>1000</mml:mn><mml:mo>×</mml:mo><mml:mfrac><mml:mrow><mml:mi>S</mml:mi><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi/><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>O</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>420</mml:mn><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>V</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi>O</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>600</mml:mn><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math></inline-formula>. Slope is estimated by linear regression, and V is the volume of culture used (in mL). The source data are provided for the bar chart showing β-galactosidase activity in <xref ref-type="fig" rid="fig3">Figure 3A</xref>, which is represented as the means and SDs of three independent experiments.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig3-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Raw autoradiogram.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-64092-fig3-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Quantification of (p)ppGpp.</title><p>The amount of (p)ppGpp was normalized to total amount of G nucleotides observed in each sample. Total G is the sum of GTP and (p)ppGpp detected. The source data are provided for the relative levels of (p)ppGpp in <xref ref-type="fig" rid="fig3">Figure 3D</xref>, which are represented as the means and SDs of three independent experiments.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig3-data3-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata4"><label>Figure 3—source data 4.</label><caption><title>Determination of Δ(lag phase).</title><p>The Δ(lag phase) corresponds to the time that separates the growth recovery of the wild-type (WT) (lag phase [WT]) from that of the Δ<italic>nirD</italic> or <italic>nirD<sup>E50K</sup></italic> (lag phase [Δ<italic>nirD</italic>, <italic>nirD<sup>E50K</sup></italic>]). For each strain, the duration of the lag phase was calculated for an OD<sub>600nm</sub> corresponding to the entry into the exponential growth phase. The equation for this calculation was estimated by linear regression on the log phase of each growth curve. The source data are provided for the Δ(lag phase) in <xref ref-type="fig" rid="fig3">Figure 3E</xref>, which are represented as the means and SDs of at least three experiments.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig3-data4-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64092-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>NirD<sup>E50K</sup> functionally interacts with NirB.</title><p>(<bold>A</bold>) Bacterial two-hybrid assay using <italic>E. coli</italic> BTH101 cells co-transformed with plasmid derivatives pKT25-<italic>nirB</italic> and pUT18C-<italic>nirD</italic> or pUT18C-<italic>nirD<sup>E50K</sup></italic>. Stationary-phase cultures were spotted on NA plates containing X-Gal as a blue color reporter for positive interaction. The bars showing β-galactosidase activity are represented as the means of three independent experiments, and the error bars depict the SDs. (<bold>B</bold>) Growth assay of <italic>E. coli</italic> MG1655 cells co-transformed with the plasmid derivatives pBbS2k-<italic>relA</italic> and pEG25-<italic>nirD</italic> or pEG25-<italic>nirBD</italic> inducible by anhydrotetracycline (aTc) and isopropyl β-D-1-thiogalactopyranoside (IPTG), respectively. Serial dilutions of stationary-phase cultures were spotted on NA plates containing the indicated concentrations of inducers. The results are representative of three independent experiments. (<bold>C</bold>) Growth curves of wild-type (WT) cells, Δ<italic>nirD,</italic> and <italic>nirD<sup>E50K</sup></italic> mutants under anaerobiosis in defined glycerol minimal medium supplemented with nitrate as the sole electron acceptor and as the sole nitrogen source (see Materials and methods). Under nitrate respiration, nitrate is converted to nitrite, which is subsequently converted to ammonium (NH<sub>4</sub>) by the cytosolic NADH-dependent nitrite reductase NirBD. Bacteria can then utilize NH<sub>4</sub> as nitrogen source. Therefore, an active NADH-dependent nitrite reductase activity is required for anaerobic growth when nitrate is the sole nitrogen source (<xref ref-type="bibr" rid="bib66">Wang et al., 2019b</xref>).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Determination of β-galactosidase activity.</title><p>The relative β-galactosidase activity was calculated as follows:<inline-formula><mml:math id="inf2"><mml:mn>1000</mml:mn><mml:mo>×</mml:mo><mml:mfrac><mml:mrow><mml:mi>S</mml:mi><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi/><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>O</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>420</mml:mn><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>V</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi>O</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>600</mml:mn><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math></inline-formula>. Slope is estimated by linear regression, and V is the volume of culture used (in mL). The source data are provided for the bar chart showing β-galactosidase activity in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>, which is represented as the means and SDs of three independent experiments.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>Raw data for growth curves.</title><p>The source data are provided for the growth curves in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>, which are represented as the means and SDs of three independent experiments.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig3-figsupp1-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64092-fig3-figsupp1-v1.tif"/></fig></fig-group><p>To further assess the significance of the NirD-RelA interaction in vivo and its role in (p)ppGpp homeostasis, we randomly mutagenized <italic>nirD</italic> and searched for defective mutants unable to interact with RelA. One of such mutants that had charge reversal amino acid substitution, glutamate 50 to lysine (E50K), displayed compromised interaction with RelA (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Importantly, we confirm that both T18-NirD and T18-NirD<sup>E50K</sup> recombinant proteins were correctly expressed and folded as shown by their ability to strongly interact with the catalytic subunit of the nitrite reductase NirB (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) (<xref ref-type="bibr" rid="bib17">Harborne et al., 1992</xref>). Importantly and on the contrary to the results obtained with the WT copy of <italic>nirD</italic>, we observed that overexpression of <italic>nirD<sup>E50K</sup></italic> is not able to suppress toxicity associated to RelA overproduction on plate (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). This result predicts that breaking the interaction with RelA abolishes the inhibitory effect of NirD on (p)ppGpp accumulation. Indeed, as shown in <xref ref-type="fig" rid="fig3">Figure 3C, D</xref>, <italic>nirD<sup>E50K</sup></italic> failed to stop the massive accumulation of (p)ppGpp observed in vivo after RelA overproduction as compared to the fast decay of (p)ppGpp observed when the WT copy of <italic>nirD</italic> is expressed (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>).</p><p><italic>nirD</italic> is a second gene of a four-gene operon (<italic>nirBDC-cysG</italic>) strongly induced under anaerobic growth (<xref ref-type="bibr" rid="bib17">Harborne et al., 1992</xref>; <xref ref-type="bibr" rid="bib42">Peakman et al., 1990b</xref>). Interestingly, we observed that Δ<italic>nirD</italic> mutant presents an extended growth recovery in anaerobic SMG liquid medium consistent with a toxic over-accumulation of (p)ppGpp in this strain (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Indeed, a chromosomal encoded <italic>nirD<sup>E50K</sup></italic> mutant, which is functional for the nitrite reductase activity (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>) but failed to interact with RelA, displays the same growth defect, suggesting that the NirD-RelA interaction is important to adjust proper (p)ppGpp level under this specific growth condition. Taken together, our results show that a specific functional interaction between RelA and NirD can lower RelA-dependent accumulation of (p)ppGpp in vivo.</p></sec><sec id="s2-5"><title>NirD targets the catalytic N-terminal region of RelA</title><p>RelA consists of several protein domains that have been encompassed in two functional regions, the catalytic NTD and the regulatory CTD. The N-terminal region includes the enzymatically inactive (p)ppGpp hydrolase domain (HYD) as well as the functional (p)ppGpp synthetase domain (SYN), while the CTD comprises the Thr-tRNA synthetase, GTPase and SpoT domain (TGS), the alpha helical domain (AH), the zinc finger domain (ZFD), and finally the RNA recognition motif domain (RRM) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>) (<xref ref-type="bibr" rid="bib7">Brown et al., 2016</xref>; <xref ref-type="bibr" rid="bib33">Loveland et al., 2016</xref>). To determine which of these domains are required for the interaction with NirD, we assayed the interaction between NirD and several truncated RelA proteins using the BTH assay.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>NirD can interact with the catalytic N-terminal region of RelA.</title><p>(<bold>A</bold>) Schematic representation of RelA and its protein domains. (<bold>B</bold>) Bacterial two-hybrid assay using <italic>E. coli</italic> BTH101 cells co-transformed with plasmid derivatives pUT18C-<italic>nirD</italic> and pKT25 with the full-length or truncated <italic>relA</italic> gene as indicated. Stationary-phase cultures were spotted on NA plates containing X-Gal as a blue color reporter for positive interaction. The bars showing β-galactosidase activity are represented as the means of three independent experiments, and the error bars depict the SDs.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Determination of β-galactosidase activity.</title><p>The relative β-galactosidase activity was calculated as follows:<inline-formula><mml:math id="inf3"><mml:mn>1000</mml:mn><mml:mo>×</mml:mo><mml:mfrac><mml:mrow><mml:mi>S</mml:mi><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi/><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>O</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>420</mml:mn><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>V</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi>O</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>600</mml:mn><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math></inline-formula>. Slope is estimated by linear regression, and V is the volume of culture used (in mL). The source data are provided for the bar chart showing β-galactosidase activity in <xref ref-type="fig" rid="fig4">Figure 4B</xref>, which is represented as the means and SDs of three independent experiments.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64092-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>The RelA<sup>N-terminal</sup>-NirD interaction appears specific.</title><p>(<bold>A</bold>) Bacterial two-hybrid assay using <italic>E. coli</italic> BTH101 cells co-transformed with plasmid derivatives pKT25-<italic>relA<sup>N-terminal</sup></italic> or pKT25-<italic>spoT<sup>N-terminal</sup></italic> and pUT18C-<italic>nirD</italic> or pUT18C-<italic>nirD<sup>E50K</sup></italic>. Stationary-phase cultures were spotted on NA plates containing X-Gal as a blue color reporter for positive interaction. The bars showing β-galactosidase activity are represented as the means of three independent experiments, and the error bars depict the SDs. (<bold>B</bold>) Growth assay of <italic>E. coli</italic> MG1655 cells co-transformed with the plasmid derivatives pBbS2k-<italic>relA<sup>N-terminal</sup></italic> and pEG25-<italic>nirD</italic> or pEG25-<italic>nirD<sup>E50K</sup></italic> inducible by anhydrotetracycline (aTc) and isopropyl β-D-1-thiogalactopyranoside (IPTG), respectively. Serial dilutions of stationary-phase cultures were spotted on NA plates containing the indicated concentrations of inducers. The results are representative of three independent experiments.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Determination of β-galactosidase activity.</title><p>The relative β-galactosidase activity was calculated as follows:<inline-formula><mml:math id="inf4"><mml:mn>1000</mml:mn><mml:mo>×</mml:mo><mml:mfrac><mml:mrow><mml:mi>S</mml:mi><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi/><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>O</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>420</mml:mn><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>V</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi>O</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>600</mml:mn><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math></inline-formula>. Slope is estimated by linear regression, and V is the volume of culture used (in mL). The source data are provided for the bar chart showing β-galactosidase activity in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>, which is represented as the means and SDs of three independent experiments.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64092-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Truncated RelA proteins were fused to the T25 domain of the <italic>B. pertussis</italic> adenylate cyclase and transformed together with NirD fused to the T18 domain in a <italic>cya</italic>-deficient <italic>E. coli</italic> strain (BTH101). BTH analysis revealed that NirD interacts with the RelA<sup>N-terminal</sup> fusion comprising the catalytic domains (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Moreover, careful quantification of β-galactosidase activity revealed that none of the four domains encompassing the CTD of RelA is required for this interaction in vivo. However, truncated RelA fusion lacking either the synthetase domain (RelA<sup>1-181</sup>) or the ‘pseudo’ hydrolase domain (RelA<sup>181-744</sup>) failed to interact in vivo with NirD. Therefore, the catalytic domains of RelA seem necessary and sufficient to interact with NirD in vivo. The specificity of the interaction between NirD and RelA was further reinforced by the absence of interaction observed between NirD and SpoT<sup>N-terminal</sup> as well as NirD<sup>E50K</sup> and RelA<sup>N-terminal</sup> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Interestingly, the C-terminal region of RelA is proposed to play a key role in the autoregulation of the enzymatic activity, and as a result the RelA<sup>N-terminal</sup> truncated protein is constitutively active (<xref ref-type="bibr" rid="bib54">Schreiber et al., 1991</xref>). Given that NirD interacts with RelA<sup>N-terminal</sup>, we therefore tested the intriguing possibility that NirD may also be able to inhibit this dysregulated variant. Remarkably, as shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>, we observed that NirD but not NirD<sup>E50K</sup> inhibits the toxicity associated with (p)ppGpp over-accumulation mediated by the constitutively active RelA<sup>N-terminal</sup>. Taken together, our results show that NirD can inhibit RelA activity by interacting with its catalytic N-terminal region in vivo.</p></sec><sec id="s2-6"><title>NirD directly binds RelA to inhibit the rate of (p)ppGpp synthesis in vitro</title><p>To confirm the in vivo interaction of NirD at the catalytic N-terminal region of RelA, we used different complementary in vitro methods. For that purpose, the RelA catalytic domains (RelA<sup>N-terminal</sup>), NirD, and NirD<sup>E50K</sup> were individually produced and purified by two consecutive chromatographies, affinity and size-exclusion (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A–C</xref>). We first performed size-exclusion chromatography (SEC) experiment separating RelA<sup>N-terminal</sup> and NirD alone or pre-mixed. As shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>, co-elution resulted in an earlier eluting peak, suggesting the formation of a stable complex. Indeed, SDS-PAGE analysis confirmed that the two proteins were co-eluted from the column (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>).</p><p>To further characterize the NirD-RelA<sup>N-terminal</sup> interaction, we then used biolayer interferometry (BLI), an in vitro approach for measuring biomolecular interactions. Biotinylated NirD was immobilized on streptavidin biosensors as ligand, and RelA<sup>N-terminal</sup> was used as the analyte. By adding RelA at concentrations ranging from 0.1 to 30 µM, a dose-response association is recorded and decreased during the dissociation step corresponding to the washing of the sensor (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), showing that NirD directly interact with the catalytic N-terminal region of RelA. Moreover, by plotting the maximum binding response against the corresponding concentrations of RelA, we calculated a dissociation constant (K<sub>D</sub>) of 0.55 µM (± 0.053 µM) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). In addition, and in agreement with the BTH assays (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), RelA<sup>N-terminal</sup> did not interact with the NirD<sup>E50K</sup> variant in vitro (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Finally, to further determine the thermodynamic parameters of the NirD-RelA<sup>N-terminal</sup> interaction, we performed isothermal titration calorimetry (ITC) experiment. The assay first confirmed the direct interaction between the two proteins with an estimated K<sub>D</sub> of 0.34 µM (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), very similar to that estimated by BLI (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). This reaction is a favorable spontaneous exothermic reaction with a ΔH kcal/mol of −3.63 ± 0.208 and is enthalpy driven at 25°C. On the contrary and consistent with BLI experiments, no heat exchange was recorded upon titration of RelA<sup>N-terminal</sup> by NirD<sup>E50K</sup>, further supporting the strong specificity of the interaction between NirD and RelA (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Collectively, these results show that NirD interacts directly and specifically with the catalytic domains of RelA in vitro.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>NirD directly interact with the catalytic N-terminal region of RelA.</title><p>(<bold>A</bold>) Biolayer interferometric assay of RelA<sup>N-terminal</sup> on NirD or NirD<sup>E50K</sup>. Biotinylated NirD or NirD<sup>E50K</sup> were immobilized on streptavidin biosensors and probed with RelA<sup>N-terminal</sup> at concentrations ranging from 0.1 to 30 µM. The curves are represented as the means of the subtracted reference binding responses during association and dissociation from three experiments, the error bars depicting the SDs. The inset curve shows the specific biolayer interferometry (BLI) response (nm) 10 s before the end of association as a function of RelA<sup>N-terminal</sup> concentration. Data are represented as the means of the three experiments, the error bars depicting the SDs. (<bold>B, C</bold>) Isothermal titration calorimetry profiles corresponding to the binding of RelA<sup>N-terminal </sup>30–300 µM NirD (<bold>B</bold>) or 300 µM NirD<sup>E50K</sup> (<bold>C</bold>) at 25°C. The upper panels show raw data for titration of NirD or NirD<sup>E50K</sup> with RelA<sup>N-terminal</sup>, and the lower panels show the integrated heats of binding obtained from the raw data. The data were fitted using a ‘One Set of Sites’ model in the PEAQ-ITC Analysis Software.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Raw data for biolayer interferometry (BLI) experiments.</title><p>The source data are provided for the BLI experiments in <xref ref-type="fig" rid="fig5">Figure 5A</xref>, which are represented as the means and SDs of three independent experiments.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig5-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Raw data for isothermal titration calorimetry experiment run with NirD.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig5-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata3"><label>Figure 5—source data 3.</label><caption><title>Raw data for isothermal titration calorimetry experiment run with NirD<sup>E50K</sup>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig5-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64092-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>NirD can directly interact with the catalytic N-terminal region of RelA.</title><p>(<bold>A–C</bold>) Purification of RelA<sup>N-terminal</sup> (<bold>A</bold>), NirD (<bold>B</bold>), and NirD<sup>E50K</sup> (<bold>C</bold>) using size-exclusion chromatography (SEC). The curves show the absorbance at 280 nm as a function of the elution volume. The SEC elution fractions indicated by arrows were analyzed by 12% SDS-PAGE. For SDS-PAGE, molecular weight markers are expressed in kDa. (<bold>D, E</bold>) SEC experiment separating RelA<sup>N-terminal</sup> and NirD alone or pre-mixed. (<bold>D</bold>) The curves show the absorbance at 280 nm as a function of the elution volume. The SEC elution fractions highlighted were analyzed by 12% SDS-PAGE (<bold>E</bold>). For SDS-PAGE, molecular weight markers are expressed in kDa.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Raw data for purification of RelA<sup>N-terminal</sup>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata2"><label>Figure 5—figure supplement 1—source data 2.</label><caption><title>Raw SDS-PAGE for RelA<sup>N-terminal</sup> purification.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-64092-fig5-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata3"><label>Figure 5—figure supplement 1—source data 3.</label><caption><title>Raw data for purification of NirD.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig5-figsupp1-data3-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata4"><label>Figure 5—figure supplement 1—source data 4.</label><caption><title>Raw SDS-PAGE for NirD purification.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-64092-fig5-figsupp1-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata5"><label>Figure 5—figure supplement 1—source data 5.</label><caption><title>Raw data for purification of NirD<sup>E50K</sup>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig5-figsupp1-data5-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata6"><label>Figure 5—figure supplement 1—source data 6.</label><caption><title>Raw SDS-PAGE for NirD<sup>E50K</sup> purification.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-64092-fig5-figsupp1-data6-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata7"><label>Figure 5—figure supplement 1—source data 7.</label><caption><title>Raw data for size-exclusion chromatography experiment separating RelA<sup>N-terminal</sup> and NirD alone or pre-mixed.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig5-figsupp1-data7-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata8"><label>Figure 5—figure supplement 1—source data 8.</label><caption><title>Raw SDS-PAGE for size-exclusion chromatography experiment.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-64092-fig5-figsupp1-data8-v1.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64092-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Finally, these results are in line with our in vivo results showing that NirD inhibits accumulation of (p)ppGpp from the constitutively active RelA<sup>N-terminal</sup> protein (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>) and therefore support a rather simple model where NirD would directly inhibit RelA synthetic activity through direct binding. To challenge this hypothesis, we performed in vitro pppGpp synthesis assay with purified proteins. We observed that RelA<sup>N-terminal</sup> protein could efficiently synthetize [<sup>32</sup>P]-pppGpp, but the addition of NirD strongly affected the synthetase activity in vitro. Indeed, 80% of GTP are converted to pppGpp within 60 min by RelA, whereas only 30% are converted when NirD is added (<xref ref-type="fig" rid="fig6">Figure 6A, B</xref>). Importantly, addition of the NirD<sup>E50K</sup> does not affect the RelA synthetic activity (<xref ref-type="fig" rid="fig6">Figure 6A, B</xref>). Finally, careful examination of the initial rates (calculated over the first 150 s) shows a concentration-dependent inhibition of RelA’s (p)ppGpp synthetic activity by NirD with a half-inhibition occurring at ∼1:1 molar ratio and a near complete inhibition for the highest tested concentration of NirD (1:16 molar ratio) (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Taken together, these results show that NirD can block pppGpp synthetase activity of RelA through a direct interaction with the catalytic domains.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>NirD inhibits RelA activity in vitro.</title><p>(<bold>A, B</bold>) In vitro pppGpp formation by 1 µM RelA<sup>N-terminal</sup> in the presence or absence of 4 µM NirD or NirD<sup>E50K</sup>. Samples collected at the indicated times were separated by thin layer chromatography (TLC). The autoradiogram (<bold>A</bold>) is representative of three experiments, and the curves of the relative levels of pppGpp (<bold>B</bold>) are represented as the means of the three experiments, the error bars depicting the SDs. (<bold>C</bold>) Relative initial velocity of RelA as a function of NirD:RelA molar ratio. The in vitro formation of pppGpp by 1 µM RelA<sup>N-terminal</sup> was assayed in the presence or absence of NirD at concentrations ranging from 0.5 to 16 µM. Samples were collected every 30 s over a period of 150 s and separated by TLC to determine the relative initial velocity (estimated by linear regression using five data points). Results are represented as the means of three experiments, and the error bars depict the SDs.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Raw autoradiogram.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-64092-fig6-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Quantification of pppGpp.</title><p>The amount of pppGpp was normalized to total amount of G nucleotides observed in each sample. Total G is the sum of GTP and pppGpp detected. The source data are provided for the relative levels of pppGpp in <xref ref-type="fig" rid="fig6">Figure 6B</xref>, which are represented as the means and SDs of three independent experiments.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig6-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Determination of the relative initial velocity.</title><p>The relative initial velocity was estimated on the linear part of the in vitro pppGpp formation by linear regression at the very beginning of the reaction. The source data are provided for the results in <xref ref-type="fig" rid="fig6">Figure 6C</xref>, which are represented as the means and SDs of three experiments.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64092-fig6-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64092-fig6-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p><italic>E. coli</italic> contains two long RSH enzymes, RelA and SpoT, that synthesize the alarmones (p)ppGpp. While SpoT is a bifunctional enzyme, RelA is monofunctional with a degenerated hydrolase domain, making SpoT the primary source of hydrolysis (<xref ref-type="bibr" rid="bib73">Xiao et al., 1991</xref>). Therefore, a fine-tune regulation of the intracellular (p)ppGpp synthetic and hydrolytic activities in bacteria is crucial to rapidly adjust (p)ppGpp level in response to environmental stress but also to prevent toxic consequences due to (p)ppGpp over-accumulation (<xref ref-type="bibr" rid="bib73">Xiao et al., 1991</xref>). Over the past decade, several molecular mechanisms regulating the activity of (p)ppGpp synthetase and/or hydrolase have been characterized (<xref ref-type="bibr" rid="bib4">Battesti and Bouveret, 2006</xref>; <xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref>; <xref ref-type="bibr" rid="bib16">Hahn et al., 2015</xref>; <xref ref-type="bibr" rid="bib26">Karstens et al., 2014</xref>; <xref ref-type="bibr" rid="bib29">Krüger et al., 2020</xref>; <xref ref-type="bibr" rid="bib31">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Peterson et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Raskin et al., 2007</xref>; <xref ref-type="bibr" rid="bib47">Ronneau et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Ronneau et al., 2019</xref>; <xref ref-type="bibr" rid="bib72">Wout et al., 2004</xref>). In this study, we uncovered an unprecedented mode of regulation that can prevent accumulation of (p)ppGpp in <italic>E. coli</italic>. This regulation implicates physical interaction in vivo and in vitro between the catalytic domains of RelA and the protein NirD, the small subunit of the cytoplasmic NADH-dependent nitrite reductase complex NirBD (<xref ref-type="bibr" rid="bib17">Harborne et al., 1992</xref>). We show that NirD can functionally and directly inhibit the RelA (p)ppGpp synthetic activity. RelA and SpoT are paralogous proteins; however, despite strong sequence homologies and similar domain architecture we were not able to notice physical interaction between NirD and SpoT (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), supporting a specific physiological role of NirD in inhibiting RelA synthetic activity. The absence of a functional link between NirD and SpoT is further reinforced by the observation that NirD does not seem to lower basal (p)ppGpp level produced by the weak (p)ppGpp synthetase activity encoded by SpoT in the absence of RelA (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>).</p><p>Stimulation of RelA synthetase activity in <italic>E. coli</italic> is driven by stalled ribosomes upon amino acid starvation (<xref ref-type="bibr" rid="bib18">Haseltine and Block, 1973</xref>; <xref ref-type="bibr" rid="bib68">Wendrich et al., 2002</xref>; <xref ref-type="bibr" rid="bib71">Winther et al., 2018</xref>). In addition, NtrC-dependent transcription of <italic>relA</italic> takes an important role in (p)ppGpp accumulation (<xref ref-type="bibr" rid="bib6">Brown et al., 2014</xref>). Therefore, the identification of a potent intracellular inhibitor of RelA (p)ppGpp synthetase represents an additional level of complexity in the regulation to the current stringent model mediated by RelA. Our results show that the NirD protein level can play an important role for adjusting intracellular (p)ppGpp levels. Indeed, ectopic induction of NirD is sufficient to prevent accumulation of (p)ppGpp mediated by RelA in the absence of nutritional stress (<xref ref-type="fig" rid="fig1">Figure 1C, D</xref>). Moreover, we show that once expressed, <italic>nirD</italic> can also totally abolish activation of the stringent response during amino acid starvation (<xref ref-type="fig" rid="fig2">Figure 2C, D</xref>). The estimated concentration of RelA is in the range of 100–400 nM in <italic>E. coli</italic> (<xref ref-type="bibr" rid="bib32">Li et al., 2014</xref>; <xref ref-type="bibr" rid="bib43">Pedersen and Kjeldgaard, 1977</xref>). Importantly, we found in vitro that the NirD-RelA affinity is characterized by a K<sub>D</sub> in this concentration range (300–550 nM) (<xref ref-type="fig" rid="fig5">Figure 5A, B</xref>). Therefore, at concentrations above the K<sub>D</sub>, NirD would interact with RelA to catalytically inhibit its activity. <italic>nirD</italic> is a second gene of a four-gene operon (<italic>nirBDC-cysG</italic>) expressed under anaerobic growth (<xref ref-type="bibr" rid="bib17">Harborne et al., 1992</xref>; <xref ref-type="bibr" rid="bib42">Peakman et al., 1990b</xref>) and maximally induced in the presence of glucose and nitrate (<xref ref-type="bibr" rid="bib62">Tyson et al., 1997</xref>; <xref ref-type="bibr" rid="bib67">Wang and Gunsalus, 2000</xref>). Under these conditions, NirD is predicted to reach µM range (<xref ref-type="bibr" rid="bib27">Khlebodarova et al., 2016</xref>) and regulation of RelA by NirD would therefore become physiologically relevant. Importantly, while NirB and NirD can form a stable complex needed for the NADH-dependent nitrite reductase activity, we observed that coexpression of <italic>nirB</italic> and <italic>nirD</italic> can still counteract RelA-dependent (p)ppGpp accumulation (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). The cytoplasmic nitrite reductase NirBD has emerged as a key regulator of the nitric oxide (NO) level during nitrate respiration (<xref ref-type="bibr" rid="bib8">Bulot et al., 2019</xref>). Indeed, by reducing nitrite generated during nitrate reduction, NirBD would limit the level of toxic nitrite and thus its further reduction to NO (<xref ref-type="bibr" rid="bib8">Bulot et al., 2019</xref>). In addition, our results present evidence that NirD can also promote bacterial fitness by adjusting (p)ppGpp levels in response to amino acid starvation under anaerobic glucose fermentation, a condition where the nitrite reductase is expressed but where the substrate is missing (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). This regulation is dependent on the RelA-NirD interaction since NirD<sup>E50K</sup>, which is not affected for the nitrite reductase activity (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>) but failed to interact with RelA (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), does not enhance bacterial fitness in response to amino acid starvation under anaerobic glucose fermentation (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Therefore, our results suggest that NirD can link (p)ppGpp homeostasis to anaerobic metabolism in <italic>E. coli</italic>. Additional analyses are currently underway to further investigate the physiological roles of the RelA-NirD interaction in <italic>E. coli</italic>.</p><p>The CTD of RSH enzymes is assumed to play key roles in sensing nutrient starvation and adjusting the enzymatic state of the NTD. In that sense, the RelA structures on stalled ribosomes emphasized the role of CTD in sensing nutrient availability. Once bound to the ribosome, RelA adopts an open extended conformation, which is thought to release the autoinhibitory effect of the CTD on the NTD, therefore promoting (p)ppGpp synthesis (<xref ref-type="bibr" rid="bib1">Arenz et al., 2016</xref>; <xref ref-type="bibr" rid="bib7">Brown et al., 2016</xref>; <xref ref-type="bibr" rid="bib33">Loveland et al., 2016</xref>). Interestingly, we observed that the NTD region of RelA is necessary and sufficient for NirD binding (<xref ref-type="fig" rid="fig4">Figure 4B</xref> and <xref ref-type="fig" rid="fig5">Figure 5</xref>). Moreover, our in vivo and in vitro results convincingly show that NirD can inhibit the (p)ppGpp synthesis from the constitutively active truncated RelA<sup>N-terminal</sup> (<xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>), supporting the idea of a ribosome-independent inhibition of the stringent response. Therefore, rather than preventing activation of RelA our results support a simple model of regulation in which NirD directly interacts with the catalytic domains of RelA to inhibit the synthetic activity. Such inhibition might be mediated by directly introducing structural changes in the catalytic domains. Alternatively, NirD may interact with RelA to avoid nucleotide binding by masking the nucleotide-binding site. Structural and functional analyses are currently under investigation to test whether direct binding of NirD inhibits RelA activity.</p><p>Finally, (p)ppGpp has emerged as an important regulator of not only the bacterial stress response but also of many aspects of bacterial physiology including virulence, immune evasion, and antibiotic tolerance. Therefore, strategies to inhibit RelA activity and the subsequent production of (p)ppGpp represent an attractive approach for the success of antimicrobial therapy. Currently, there are only a limited number of synthetic inhibitors known to target RelA, mainly based on the design of (p)ppGpp analogues (<xref ref-type="bibr" rid="bib69">Wexselblatt et al., 2012</xref>; <xref ref-type="bibr" rid="bib70">Wexselblatt et al., 2013</xref>). Hence, our identification that NirD constitutes a natural potent inhibitor of RelA in vivo and in vitro could represent an important resource for the future design of new drug compounds. Importantly, it is also likely to be a fascinating molecular tool to further tackle the functional and structural determinant of the stringent response.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Experimental model and subject details</title><p>The <italic>E. coli</italic> strains and plasmids used in this study are listed in Appendix 1—key resources table. Cells were grown in lysogeny broth (LB) broth (<xref ref-type="bibr" rid="bib36">Miller, 1972</xref>) with agitation or on NA (Thermo Fisher Scientific, MA). For cells containing plasmid(s), the media were appropriately supplemented with the antibiotic(s) kanamycin (25 µg/mL), chloramphenicol (50 µg/mL), and/or ampicillin (50 µg/mL).</p></sec><sec id="s4-2"><title>Plasmids construction</title><p>The plasmid derivatives were constructed by cloning into a plasmid a gene amplified by PCR from template DNA (chromosomal or plasmid) using the primers listed in Appendix 1—key resources table. The restriction enzymes as well as Shine-Dalgarno sequence for the pEG25 and pBbS2k plasmids are also indicated (Appendix 1—key resources table).</p></sec><sec id="s4-3"><title>Multicopy suppressor screen</title><p>The genetic assay for the identification of new regulator of (p)ppGpp homeostasis in <italic>E. coli</italic> was carried out as follows. A pool of plasmids from the ASKA library (<xref ref-type="bibr" rid="bib28">Kitagawa et al., 2005</xref>) was introduced by electroporation into <italic>E. coli</italic> MG1655 cells containing the pBbS2k-<italic>relA</italic>. The transformed cells were then spread on NA plates containing the appropriate antibiotics and the inducers aTc (0 or 100 ng/mL) and IPTG (0, 100, or 200 µM) for induction of pBbS2k-<italic>relA</italic> and pCA24N derivatives from the ASKA library, respectively. After 36 hr of incubation at 37°C, clones that were able to form colonies under these non-permissive conditions were chosen for the plasmid preparation and sequencing. The pool of plasmids from the ASKA library was obtained by <xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref>.</p></sec><sec id="s4-4"><title>Growth assay</title><p>The ability of <italic>E. coli</italic> cells to grow under specific conditions was tested as follows. Single colonies were inoculated into 2 mL of LB broth, supplemented with the appropriate antibiotic(s), and cultured at 37°C until stationary phase (~8 hr). The cultures were then serially diluted and spotted on NA, M9-glucose minimal medium, or SMG plates (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) containing the appropriate antibiotic(s) and plasmid inducer(s). For growth assays on M9-glucose minimal medium or SMG, the cultures were washed twice and diluted in PBS before being serially diluted and spotted on agar plates. The cells were finally incubated at 37°C overnight or ~36 hr depending on whether they were spotted on NA or minimal medium, respectively.</p></sec><sec id="s4-5"><title>In vivo (p)ppGpp measurement</title><p>The levels of (p)ppGpp in the cells were determined as described by <xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref>. Briefly, 100 µL of <sup>32</sup>P-labeled cell samples were taken at set times and added to 40 µL of ice-cold 21 M formic acid to stop the reactions. The mixtures were then placed on ice for 20 min before being centrifuged at 4°C for 20 min at 14,000 <italic>g</italic> to pellet cell debris and avoid them on chromatograms. 5 µL of each were loaded onto PEI-Cellulose thin layer chromatography (TLC) plates (Merck-Millipore) prior to ascending development with 1.5 M KH<sub>2</sub>PO<sub>4</sub> solution (pH 3.4). Once fully developed, the TLC plates were dry at room temperature, separated from their upper part containing free <sup>32</sup>P, and exposed overnight with a phosphor screen. The signals from the phosphor screen were then captured and quantified using an Amersham Typhoon Biomolecular Imager and ImageQuant TL 8.1 (GE Healthcare). We normalized the amount of (p)ppGpp to the total amount of G nucleotides observed in each sample, the total G being the sum of GTP, ppGpp, and pppGpp detected.</p><p>Regarding the preparation of the media, the labeling with <sup>32</sup>P, and the induction of stress or starvation, they were carried out as follows. For overnight cultures, cells were grown in MOPS minimal medium (<xref ref-type="bibr" rid="bib39">Neidhardt et al., 1974</xref>) supplemented with 0.2% glucose, 2 mM phosphate, and amino acids at 40 µg/mL (except for amino acid starvation experiment). Cultures were diluted 100 times in the same medium with 0.4 mM phosphate and incubated at 37°C with shaking. At an OD<sub>600nm</sub> of ~0.5, they were diluted to an OD<sub>600nm</sub> of 0.05, labeled with 150 µCi of <sup>32</sup>P, and grew to an OD<sub>600nm</sub> of ~0.20. At this point and 30 min later, inducers (100 ng/mL aTc or 1 mM IPTG) or 500 µg/mL L-valine were added for gene overexpression or induction of isoleucine starvation, respectively.</p></sec><sec id="s4-6"><title>Bacterial two-hybrid assay</title><p>In vivo protein-protein interactions were tested using the bacterial two-hybrid system (<xref ref-type="bibr" rid="bib25">Karimova et al., 1998</xref>). Briefly, protein pairs were fused to the T18 and T25 domains of <italic>B. pertussis</italic> adenylate cyclase using the two compatible vectors pUT18C and pKT25, respectively. Co-transformed with the pairs of plasmids, single colonies of the <italic>cya</italic>-deficient strain BTH101 were inoculated into 2 mL of LB broth supplemented with ampicillin and kanamycin, and grown at 30°C to stationary phase (~12 hr). 5 µL of the cultures were then spotted on NA plates containing the two antibiotics and 40 µg/mL X-gal as a color reporter for β-galactosidase and adenylate cyclase activities. The cells were finally incubated at 30°C ~36 hr. To quantify the strength of the interaction, β-galactosidase activity was determined as described by <xref ref-type="bibr" rid="bib37">Miller, 1992</xref> using stationary phase culture (~12 hr).</p></sec><sec id="s4-7"><title>Screening for loss of interaction by <italic>nirD</italic> random mutagenesis</title><p><italic>nirD </italic>DNA coding sequence was mutagenized randomly through low-fidelity GoTaq polymerase amplification from pUT18C-<italic>nirD</italic> plasmid using 441 and 443 oligonucleotides (Appendix 1—key resources table). After 30 PCR cycles, amplified DNA was purified, diluted to 1:100,000 and further amplified for 30 cycles. Purified DNA were cloned into pUT18C plasmid. BTH101 cells harboring pKT25<italic>-relA</italic> were then transformed with the resulting pUT18C-<italic>nirD</italic> mutated library and screened on X-Gal plates. White colonies were selected and sequenced.</p></sec><sec id="s4-8"><title>MG1655 <italic>nirD<sup>E50K</sup></italic> construction</title><p>The chromosomal mutant strain <italic>nirD<sup>E50K</sup></italic> was constructed by scarless mutagenesis using a two-step lambda Red system adapted from <xref ref-type="bibr" rid="bib5">Blank et al., 2011</xref>. DNA fragments containing a chloramphenicol resistance marker and the meganuclease I-<italic>SceI</italic> recognition site were amplified by PCR using primers 629 and 630 with pWRG100 as template. The resulting PCR product was electroporated into MG1655 cells, which had induced lambda recombinase expression for 1 hr from plasmid pKD46 (<xref ref-type="bibr" rid="bib11">Datsenko and Wanner, 2000</xref>). After 1 hr of phenotypic expression, the cells were plated on NA plates containing 25 µg/mL chloramphenicol. Selected colonies contained the <italic>nirD::cat</italic> I-<italic>Sce</italic>I allele, which was subsequently transduced in MG1655 cells harboring the pWRG99 plasmid (<xref ref-type="bibr" rid="bib5">Blank et al., 2011</xref>). The mutant allele <italic>nirD<sup>E50K</sup></italic> was amplified from pEG25-<italic>nirD<sup>E50K</sup></italic> using primers 655 and 656. The PCR product was then electroporated into MG1655 <italic>nirD::cat</italic> I-<italic>Sce</italic>I expressing lambda recombinase from pWRG99 and after 1 hr of phenotypic expression, cells were serially diluted and plated on NA plates containing 100 µg/mL ampicillin and 1 µg/mL aTc. pWRG99 also encoded for the meganuclease I-<italic>Sce</italic>I under the control of an aTc-inducible promoter. The proper integration of the <italic>nirD<sup>E50K</sup></italic> was confirmed by diagnostic PCR and sequencing.</p></sec><sec id="s4-9"><title>Growth curves</title><p>Growth of WT cells, Δ<italic>nirD,</italic> and <italic>nirD<sup>E50K</sup></italic> mutants was measured under anaerobiosis as follows. Stationary-phase cultures were washed in PBS, diluted to an OD<sub>600nm</sub> of ~0.03 in M9-glucose minimal medium without amino acids or supplement with 1 mM SMG in Hungate tubes, and air was evacuated and replaced with N<sub>2</sub>. The cultures were then incubated at 37°C and growth was followed by measurement of OD<sub>600nm</sub>. Although at least three independent experiments were performed, representative growth curves are shown. Indeed, day-to-day variations in medium composition shifted the curves slightly, but the sample-to-sample comparisons were invariable.</p><p>For the functional test of the NADH-dependent nitrite reductase activity, the cultures were prepared as described above except that they were diluted in a defined medium supplemented with 140 mM glycerol and 100 mM nitrate. The defined medium is composed of Na<sub>2</sub>HPO<sub>4</sub> (60 mM), KH<sub>2</sub>PO<sub>4</sub> (22 mM), NaCl (8 mM), MgSO<sub>4</sub> (1 mM), CaCl<sub>2</sub> (100 µM), thiamine (1 µg/mL), sodium molybdate (5 µM), sodium selenite (1 µM), and FeSO<sub>4</sub> (10 µM).</p></sec><sec id="s4-10"><title>Protein expression and production</title><p>BL21 (DE3)-competent cells were transformed with the pEG25-<italic>relA<sup>N-terminal</sup></italic>, pET28a(+)-<italic>nirD</italic> or pET28a(+)-<italic>nirD<sup>E50K</sup></italic> and plated on selective NA. For RelA<sup>N-terminal</sup> production, several colonies were picked up and inoculated into 100 mL LB containing 100 µg/mL ampicillin. The cultures were grown with shaking at 30°C overnight. Overnight cultures were dispersed as inoculum of 20 mL aliquots into 1 L Terrific Broth media with 100 µg/mL ampicillin and shaken at 30°C until OD<sub>600nm</sub> ~0.5, then cells were induced with 0.5 mM IPTG and incubated at 30°C for 4 hr. For NirD and NirD<sup>E50K</sup> production, several colonies were picked up and inoculated into 100 mL LB containing 50 µg/mL kanamycin. The cultures were grown with shaking at 30°C overnight. Overnight cultures were dispersed as inoculum of 20 mL aliquots into 1 L LB media with 50 µg/mL kanamycin and shaken at 30°C until OD<sub>600nm </sub>~0.5, then cells were induced with 0.5 mM IPTG and incubated at 30°C for 4 hr. Finally, cells were centrifuged at 9000 <italic>g</italic> for 20 min at 4°C. Dry cell pellet was stored at −80°C.</p></sec><sec id="s4-11"><title>Protein purification</title><p>For NirD and NirD<sup>E50K</sup> purification, cells were suspended in lysis buffer (50 mM Tris-HCl [pH 8.0], 300 mM NaCl, 1 mM EDTA, 0.5 mg/mL lysozyme, 1 mM phenylmethylsulfonyl fluoride [PMSF], 20 µg/mL DNase, and 20 mM MgCl<sub>2</sub>), incubated for 1 hr at 4°C with gentle shaking, and then subjected to three cycles of French-press lysis steps. The soluble fraction was obtained by centrifugation for 20 min at 200,000 <italic>g</italic>. Recombinant proteins were purified by ion metal affinity chromatography using a 5 mL nickel (HiTrap<sup>HP</sup>) column on an ÄKTA pure 25 (GE Healthcare) pre-equilibrated in 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, and 10 mM imidazole (buffer A). After several washes in buffer A, His-tagged proteins were eluted in buffer A supplemented with 250 mM imidazole and directly desalted using HiPrep 26/10 Desalting column pre-equilibrated with buffer A. The desalted proteins were mixed with 0.2 mg/mL of TEV protease, incubated for 2 hr at 25°C, and then loaded onto a HisTrap column pre-equilibrated in buffer A to retain TEV, TRX, uncleaved proteins, and contaminants. Untagged NirD or NirD<sup>E50K</sup> were collected in the flow-through, concentrated on a Centricon (Millipore; cutoff of 3 kDa), and passed through a HiLoad 16/600 Superdex 200 column pre-equilibrated with 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 2 mM β-mercaptoethanol, and 2% glycerol. The purity of NirD preparations was assessed by SDS-PAGE (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B, C</xref>).</p><p>For RelA<sup>N-terminal</sup> purification, cells were suspended in lysis buffer (50 mM Tris-HCl [pH 8.0], 500 mM NaCl, 10 mM imidazole, 2 mM β-mercaptoethanol, 0.5% CHAPS, 2% glycerol, 1 mM EDTA, 0.5 mg/mL lysozyme, 1 mM PMSF, 20 µg/mL DNase, and 20 mM MgCl<sub>2</sub>), incubated for 1 hr at 4°C with gentle shaking, and then subjected to three cycles of French-press lysis steps. The soluble fraction was obtained by centrifugation for 20 min at 200,000 <italic>g</italic>. Recombinant proteins were purified by ion metal affinity chromatography using a 5 mL nickel (HiTrap<sup>HP</sup>) column on an ÄKTA pure 25 (GE Healthcare) pre-equilibrated with equilibrium buffer (50 mM Tris-HCl [pH 8.0], 500 mM NaCl, 10 mM imidazole, 2 mM β-mercaptoethanol, and 2% glycerol), eluted in elution buffer (50 mM Tris-HCl [pH 8.0], 250 mM NaCl, 500 mM imidazole, 2 mM β-mercaptoethanol, and 2% glycerol), and directly desalted using HiPrep 26/10 Desalting column pre-equilibrated with buffer containing 50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 500 mM KCl, 2 mM β-mercaptoethanol, and 2% glycerol. Desalted proteins were concentrated on a Centricon (Millipore; cutoff of 10 kDa) and then subjected to SEC purification using a HiLoad 16/600 Superdex 200 column pre-equilibrated with 50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 500 mM KCl, 2 mM β-mercaptoethanol, and 2% glycerol. The purity of RelA preparations was assessed by SDS-PAGE (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>).</p></sec><sec id="s4-12"><title>Protein-protein interaction analysis by SEC</title><p>Purified RelA<sup>N-terminal</sup> and NirD were either alone or pre-mixed in a 1:1 ratio (10 µM each) in buffer containing 50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 500 mM KCl, 2 mM β-mercaptoethanol, and 2% glycerol prior separation on a Superdex 200 10/300 GL using an ÄKTA pure 25 apparatus (GE Healthcare) pre-equilibrated with the same buffer. Elution fractions were then analyzed with SDS-PAGE.</p></sec><sec id="s4-13"><title>Biolayer interferometry</title><p>NirD or NirD<sup>E50K</sup> were biotinylated using the EZ-Link NHS-PEG4-Biotin (Thermo Scientific) at 4°C for 2 hr. The reaction was stopped by removing the excess of the biotin using a Zeba Spin Desalting column (Thermo Scientific). BLI studies were performed at 25°C using the Blitz apparatus (FortéBio) with shaking at 2200 rpm with the following steps: 30 s baseline, 120 s association, and 120 s dissociation. Streptavidin biosensor tips (FortéBio) were hydrated with 0.350 mL of 50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 500 mM KCl, 2 mM β-mercaptoethanol, and 2% glycerol for 10 min and then loaded with 3 µM of biotinylated NirD or NirD<sup>E50K</sup> in the same buffer. The biosensors were then incubated with 10 µg/mL biocytin in interaction buffer (50 mM Tris-HCl [pH 8.0], 500 mM NaCl, 500 mM KCl, 2 mM β-mercaptoethanol, 2% glycerol, and 1 mg/mL) for 90 s to avoid the non-specific binding RelA<sup>N-terminal</sup> to the streptavidin biosensors. To study the binding of NirD or NirD<sup>E50K</sup> to RelA<sup>N-terminal</sup>, increasing concentrations RelA<sup>N-terminal </sup>(1–30 µM) in interaction buffer were used and the association and dissociation phases were monitored, respectively. In all experiments, the BLItz Pro Software performed a reference subtraction of the RelA<sup>N-terminal</sup> protein response on the uncoated biosensors for each tested concentration. The dissociation constant (K<sub>D</sub>), that is affinity of NirD to RelA<sup>N-terminal</sup>, was estimated using the GraphPad Prism 5.0 software on the basis of the steady-state-level responses in nm at equilibrium. The K<sub>D</sub> was estimated by plotting on x axis the different concentrations and the different responses of RelA<sup>N-terminal</sup> at the saturation (10 s before the end of the association) on the y axis. For K<sub>D</sub> calculation, a nonlinear regression fit for xy analysis was used and one site (specific binding) as a model [corresponding to the equation y=Bmax*x/(K<sub>D</sub>+x)].</p></sec><sec id="s4-14"><title>Isothermal titration calorimetry</title><p>ITC was performed to determine the affinity between NirD and RelA<sup>N-terminal</sup>. In a typical setup, RelA<sup>N-terminal</sup> (30 µM) in buffer containing 50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 500 mM KCl, 2 mM β-mercaptoethanol, and 2% glycerol was placed in the cell, and NirD (or NirD<sup>E50K</sup>) ligand (300 μM in the same buffer) was placed in the titration syringe. All experiments were carried out at 25°C with a stirring speed of 750 rpm and a reference power of 5 µcal/s using the MicroCal PEAQ-ITC (Malvern Panalytical) with 19 injections (0.4 µL for the initial injection and 2 µL for the next 18). Each injection lasted for 4 s with a space of 150 s between each injection. ITC measures the energy released or absorbed by a chemical reaction, and the energy of the interaction is proportional to the amount of ligand that binds to the protein. These heat pulses are recorded for each injection and then integrated with respect to time and are normalized to the concentration of the reaction to generate kcal/mol versus the molar ratio (ligand/sample). The enthalpy of the reaction is obtained, and with a ‘One Set of Sites’ model in the PEAQ-ITC Analysis Software, the K<sub>D</sub> and stoichiometry is determined. The fitted offset option in the PEAQ-ITC Analysis Software was used to correct for the heat of the dilution.</p></sec><sec id="s4-15"><title>pppGpp synthesis assay</title><p>The pppGpp synthetic activity of RelA<sup>N-terminal</sup> was assayed at 37°C in a buffer containing 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 2 mM β-mercaptoethanol, 2% glycerol, and 15 mM Mg<sup>2+</sup>. Typically, reaction mixtures contained 8 mM ATP, 6 mM GTP and [α-<sup>32</sup>P]GTP, 1 µM RelA<sup>N-terminal</sup> with or without NirD (or NirD<sup>E50K</sup>) at concentrations ranging from 0.5 to 16 µM, and reactions were started by adding pre-warmed nucleotides to the protein(s). During the time course of the reaction, 20 µL samples were taken and added to 8 µL of ice-cold 21 M formic acid to stop the reactions. The time points were resolved by TLC, and radio-labeled nucleotides were quantified as described in the ‘In vivo (p)ppGpp measurement’ section.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This work was supported by the European Research Council starting grant (ERC StG) under the European Union’s Horizon 2020 and innovation program grant agreement no. 714934 ‘Stringency’ to EM. We thank Farida Seduk, Aurore Jacq-Bailly, Gaël Brasseur, Axel Magalon, and Benjamin Ezraty for advices and stimulating discussions for anaerobic experiments.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Supervision, Validation, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Data curation, Supervision, Funding acquisition, Validation, Investigation, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Media used in this work.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-64092-supp1-v1.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-64092-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 1, Figure 2, Figure 3, Figure 4, Figure 5, Figure 6, Figure 3-figure supplement 1, Figure 4-figure supplement 1 and Figure 5-figure supplement 1.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arenz</surname> <given-names>S</given-names></name><name><surname>Abdelshahid</surname> <given-names>M</given-names></name><name><surname>Sohmen</surname> <given-names>D</given-names></name><name><surname>Payoe</surname> <given-names>R</given-names></name><name><surname>Starosta</surname> <given-names>AL</given-names></name><name><surname>Berninghausen</surname> <given-names>O</given-names></name><name><surname>Hauryliuk</surname> <given-names>V</given-names></name><name><surname>Beckmann</surname> <given-names>R</given-names></name><name><surname>Wilson</surname> <given-names>DN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The stringent factor RelA adopts an open conformation on the ribosome to stimulate ppGpp synthesis</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>6471</fpage><lpage>6481</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw470</pub-id><pub-id pub-id-type="pmid">27226493</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkinson</surname> <given-names>GC</given-names></name><name><surname>Tenson</surname> <given-names>T</given-names></name><name><surname>Hauryliuk</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The RelA/SpoT homolog (RSH) superfamily: distribution and functional evolution of ppGpp synthetases and hydrolases across the tree of life</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e23479</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0023479</pub-id><pub-id pub-id-type="pmid">21858139</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname> <given-names>T</given-names></name><name><surname>Ara</surname> <given-names>T</given-names></name><name><surname>Hasegawa</surname> <given-names>M</given-names></name><name><surname>Takai</surname> <given-names>Y</given-names></name><name><surname>Okumura</surname> <given-names>Y</given-names></name><name><surname>Baba</surname> <given-names>M</given-names></name><name><surname>Datsenko</surname> <given-names>KA</given-names></name><name><surname>Tomita</surname> <given-names>M</given-names></name><name><surname>Wanner</surname> <given-names>BL</given-names></name><name><surname>Mori</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Construction of <italic>Escherichia coli</italic> K-12 in-frame, single-gene knockout mutants: the keio collection</article-title><source>Molecular Systems Biology</source><volume>2</volume><elocation-id>2006.0008</elocation-id><pub-id pub-id-type="doi">10.1038/msb4100050</pub-id><pub-id pub-id-type="pmid">16738554</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battesti</surname> <given-names>A</given-names></name><name><surname>Bouveret</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Acyl carrier protein/SpoT interaction, the switch linking SpoT-dependent stress response to fatty acid metabolism</article-title><source>Molecular Microbiology</source><volume>62</volume><fpage>1048</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05442.x</pub-id><pub-id pub-id-type="pmid">17078815</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blank</surname> <given-names>K</given-names></name><name><surname>Hensel</surname> <given-names>M</given-names></name><name><surname>Gerlach</surname> <given-names>RG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rapid and highly efficient method for scarless mutagenesis within the <italic>Salmonella enterica</italic> chromosome</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e15763</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0015763</pub-id><pub-id pub-id-type="pmid">21264289</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>DR</given-names></name><name><surname>Barton</surname> <given-names>G</given-names></name><name><surname>Pan</surname> <given-names>Z</given-names></name><name><surname>Buck</surname> <given-names>M</given-names></name><name><surname>Wigneshweraraj</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Nitrogen stress response and stringent response are coupled in <italic>Escherichia coli</italic></article-title><source>Nature Communications</source><volume>5</volume><elocation-id>4115</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms5115</pub-id><pub-id pub-id-type="pmid">24947454</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>A</given-names></name><name><surname>Fernández</surname> <given-names>IS</given-names></name><name><surname>Gordiyenko</surname> <given-names>Y</given-names></name><name><surname>Ramakrishnan</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ribosome-dependent activation of stringent control</article-title><source>Nature</source><volume>534</volume><fpage>277</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1038/nature17675</pub-id><pub-id pub-id-type="pmid">27279228</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulot</surname> <given-names>S</given-names></name><name><surname>Audebert</surname> <given-names>S</given-names></name><name><surname>Pieulle</surname> <given-names>L</given-names></name><name><surname>Seduk</surname> <given-names>F</given-names></name><name><surname>Baudelet</surname> <given-names>E</given-names></name><name><surname>Espinosa</surname> <given-names>L</given-names></name><name><surname>Pizay</surname> <given-names>MC</given-names></name><name><surname>Camoin</surname> <given-names>L</given-names></name><name><surname>Magalon</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Clustering as a means to control nitrate respiration efficiency and toxicity in <italic>Escherichia coli</italic></article-title><source>mBio</source><volume>10</volume><elocation-id>e01832-19</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01832-19</pub-id><pub-id pub-id-type="pmid">31641084</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cashel</surname> <given-names>M</given-names></name><name><surname>Gallant</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1969">1969</year><article-title>Two compounds implicated in the function of the RC gene of <italic>Escherichia coli</italic></article-title><source>Nature</source><volume>221</volume><fpage>838</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1038/221838a0</pub-id><pub-id pub-id-type="pmid">4885263</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corrigan</surname> <given-names>RM</given-names></name><name><surname>Bellows</surname> <given-names>LE</given-names></name><name><surname>Wood</surname> <given-names>A</given-names></name><name><surname>Gründling</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>ppGpp negatively impacts ribosome assembly affecting growth and antimicrobial tolerance in Gram-positive bacteria</article-title><source>PNAS</source><volume>113</volume><fpage>E1710</fpage><lpage>E1719</lpage><pub-id pub-id-type="doi">10.1073/pnas.1522179113</pub-id><pub-id pub-id-type="pmid">26951678</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datsenko</surname> <given-names>KA</given-names></name><name><surname>Wanner</surname> <given-names>BL</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>One-step inactivation of chromosomal genes in <italic>Escherichia coli</italic> K-12 using PCR products</article-title><source>PNAS</source><volume>97</volume><fpage>6640</fpage><lpage>6645</lpage><pub-id pub-id-type="doi">10.1073/pnas.120163297</pub-id><pub-id pub-id-type="pmid">10829079</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durfee</surname> <given-names>T</given-names></name><name><surname>Hansen</surname> <given-names>AM</given-names></name><name><surname>Zhi</surname> <given-names>H</given-names></name><name><surname>Blattner</surname> <given-names>FR</given-names></name><name><surname>Jin</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Transcription profiling of the stringent response in <italic>Escherichia coli</italic></article-title><source>Journal of Bacteriology</source><volume>190</volume><fpage>1084</fpage><lpage>1096</lpage><pub-id pub-id-type="doi">10.1128/JB.01092-07</pub-id><pub-id pub-id-type="pmid">18039766</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Germain</surname> <given-names>E</given-names></name><name><surname>Guiraud</surname> <given-names>P</given-names></name><name><surname>Byrne</surname> <given-names>D</given-names></name><name><surname>Douzi</surname> <given-names>B</given-names></name><name><surname>Djendli</surname> <given-names>M</given-names></name><name><surname>Maisonneuve</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>YtfK activates the stringent response by triggering the alarmone synthetase SpoT in <italic>Escherichia coli</italic></article-title><source>Nature Communications</source><volume>10</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/s41467-019-13764-4</pub-id><pub-id pub-id-type="pmid">31848343</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gratani</surname> <given-names>FL</given-names></name><name><surname>Horvatek</surname> <given-names>P</given-names></name><name><surname>Geiger</surname> <given-names>T</given-names></name><name><surname>Borisova</surname> <given-names>M</given-names></name><name><surname>Mayer</surname> <given-names>C</given-names></name><name><surname>Grin</surname> <given-names>I</given-names></name><name><surname>Wagner</surname> <given-names>S</given-names></name><name><surname>Steinchen</surname> <given-names>W</given-names></name><name><surname>Bange</surname> <given-names>G</given-names></name><name><surname>Velic</surname> <given-names>A</given-names></name><name><surname>Maček</surname> <given-names>B</given-names></name><name><surname>Wolz</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Regulation of the opposing (p)ppGpp synthetase and hydrolase activities in a bifunctional RelA/SpoT homologue from <italic>Staphylococcus aureus</italic></article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>e1007514</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007514</pub-id><pub-id pub-id-type="pmid">29985927</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gropp</surname> <given-names>M</given-names></name><name><surname>Strausz</surname> <given-names>Y</given-names></name><name><surname>Gross</surname> <given-names>M</given-names></name><name><surname>Glaser</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Regulation of <italic>Escherichia coli</italic> RelA requires oligomerization of the C-terminal domain</article-title><source>Journal of Bacteriology</source><volume>183</volume><fpage>570</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1128/JB.183.2.570-579.2001</pub-id><pub-id pub-id-type="pmid">11133950</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname> <given-names>J</given-names></name><name><surname>Tanner</surname> <given-names>AW</given-names></name><name><surname>Carabetta</surname> <given-names>VJ</given-names></name><name><surname>Cristea</surname> <given-names>IM</given-names></name><name><surname>Dubnau</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ComGA-RelA interaction and persistence in the <italic>Bacillus subtilis</italic> K-state</article-title><source>Molecular Microbiology</source><volume>97</volume><fpage>454</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1111/mmi.13040</pub-id><pub-id pub-id-type="pmid">25899641</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harborne</surname> <given-names>NR</given-names></name><name><surname>Griffiths</surname> <given-names>L</given-names></name><name><surname>Busby</surname> <given-names>SJ</given-names></name><name><surname>Cole</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Transcriptional control, translation and function of the products of the five open reading frames of the <italic>Escherichia coli</italic> nir operon</article-title><source>Molecular Microbiology</source><volume>6</volume><fpage>2805</fpage><lpage>2813</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.1992.tb01460.x</pub-id><pub-id pub-id-type="pmid">1435259</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haseltine</surname> <given-names>WA</given-names></name><name><surname>Block</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1973">1973</year><article-title>Synthesis of guanosine tetra- and pentaphosphate requires the presence of a codon-specific, uncharged transfer ribonucleic acid in the acceptor site of ribosomes</article-title><source>PNAS</source><volume>70</volume><fpage>1564</fpage><lpage>1568</lpage><pub-id pub-id-type="doi">10.1073/pnas.70.5.1564</pub-id><pub-id pub-id-type="pmid">4576025</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauryliuk</surname> <given-names>V</given-names></name><name><surname>Atkinson</surname> <given-names>GC</given-names></name><name><surname>Murakami</surname> <given-names>KS</given-names></name><name><surname>Tenson</surname> <given-names>T</given-names></name><name><surname>Gerdes</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Recent functional insights into the role of (p)ppGpp in bacterial physiology</article-title><source>Nature Reviews Microbiology</source><volume>13</volume><fpage>298</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3448</pub-id><pub-id pub-id-type="pmid">25853779</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hengge</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Linking bacterial growth, survival, and multicellularity - small signaling molecules as triggers and drivers</article-title><source>Current Opinion in Microbiology</source><volume>55</volume><fpage>57</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2020.02.007</pub-id><pub-id pub-id-type="pmid">32244175</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogg</surname> <given-names>T</given-names></name><name><surname>Mechold</surname> <given-names>U</given-names></name><name><surname>Malke</surname> <given-names>H</given-names></name><name><surname>Cashel</surname> <given-names>M</given-names></name><name><surname>Hilgenfeld</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Conformational antagonism between opposing active sites in a bifunctional RelA/SpoT homolog modulates (p)ppGpp metabolism during the stringent response [corrected]</article-title><source>Cell</source><volume>117</volume><fpage>57</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(04)00260-0</pub-id><pub-id pub-id-type="pmid">15066282</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irving</surname> <given-names>SE</given-names></name><name><surname>Choudhury</surname> <given-names>NR</given-names></name><name><surname>Corrigan</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The stringent response and physiological roles of (pp)pGpp in bacteria</article-title><source>Nature Reviews Microbiology</source><volume>19</volume><fpage>256</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1038/s41579-020-00470-y</pub-id><pub-id pub-id-type="pmid">33149273</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irving</surname> <given-names>SE</given-names></name><name><surname>Corrigan</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Triggering the stringent response: signals responsible for activating (p)ppGpp synthesis in bacteria</article-title><source>Microbiology</source><volume>164</volume><fpage>268</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1099/mic.0.000621</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanjee</surname> <given-names>U</given-names></name><name><surname>Ogata</surname> <given-names>K</given-names></name><name><surname>Houry</surname> <given-names>WA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Direct binding targets of the stringent response alarmone (p)ppGpp</article-title><source>Molecular Microbiology</source><volume>85</volume><fpage>1029</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2012.08177.x</pub-id><pub-id pub-id-type="pmid">22812515</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karimova</surname> <given-names>G</given-names></name><name><surname>Pidoux</surname> <given-names>J</given-names></name><name><surname>Ullmann</surname> <given-names>A</given-names></name><name><surname>Ladant</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>A bacterial two-hybrid system based on a reconstituted signal transduction pathway</article-title><source>PNAS</source><volume>95</volume><fpage>5752</fpage><lpage>5756</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.10.5752</pub-id><pub-id pub-id-type="pmid">9576956</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karstens</surname> <given-names>K</given-names></name><name><surname>Zschiedrich</surname> <given-names>CP</given-names></name><name><surname>Bowien</surname> <given-names>B</given-names></name><name><surname>Stülke</surname> <given-names>J</given-names></name><name><surname>Görke</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Phosphotransferase protein EIIANtr interacts with SpoT, a key enzyme of the stringent response, in Ralstonia eutropha H16</article-title><source>Microbiology</source><volume>160</volume><fpage>711</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1099/mic.0.075226-0</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khlebodarova</surname> <given-names>TM</given-names></name><name><surname>Ree</surname> <given-names>NA</given-names></name><name><surname>Likhoshvai</surname> <given-names>VA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>On the control mechanisms of the nitrite level in <italic>Escherichia coli</italic> cells: the mathematical model</article-title><source>BMC Microbiology</source><volume>16 Suppl 1</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1186/s12866-015-0619-x</pub-id><pub-id pub-id-type="pmid">26823079</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitagawa</surname> <given-names>M</given-names></name><name><surname>Ara</surname> <given-names>T</given-names></name><name><surname>Arifuzzaman</surname> <given-names>M</given-names></name><name><surname>Ioka-Nakamichi</surname> <given-names>T</given-names></name><name><surname>Inamoto</surname> <given-names>E</given-names></name><name><surname>Toyonaga</surname> <given-names>H</given-names></name><name><surname>Mori</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Complete set of ORF clones of <italic>Escherichia coli</italic> ASKA library (a complete set of <italic>E. coli</italic> K-12 ORF archive): unique resources for biological research</article-title><source>DNA Research</source><volume>12</volume><fpage>291</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1093/dnares/dsi012</pub-id><pub-id pub-id-type="pmid">16769691</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Krüger</surname> <given-names>L</given-names></name><name><surname>Herzberg</surname> <given-names>C</given-names></name><name><surname>Wicke</surname> <given-names>D</given-names></name><name><surname>Bähre</surname> <given-names>H</given-names></name><name><surname>Heidemann</surname> <given-names>JL</given-names></name><name><surname>Dickmanns</surname> <given-names>A</given-names></name><name><surname>Schmitt</surname> <given-names>K</given-names></name><name><surname>Ficner</surname> <given-names>R</given-names></name><name><surname>Stülke</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A rendezvous of two second messengers: the c-di-AMP receptor protein DarB controls (p)ppGpp synthesis in <italic>Bacillus subtilis</italic></article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.08.27.268672</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>TS</given-names></name><name><surname>Krupa</surname> <given-names>RA</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Hajimorad</surname> <given-names>M</given-names></name><name><surname>Holtz</surname> <given-names>WJ</given-names></name><name><surname>Prasad</surname> <given-names>N</given-names></name><name><surname>Lee</surname> <given-names>SK</given-names></name><name><surname>Keasling</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>BglBrick vectors and datasheets: A synthetic biology platform for gene expression</article-title><source>Journal of Biological Engineering</source><volume>5</volume><elocation-id>12</elocation-id><pub-id pub-id-type="doi">10.1186/1754-1611-5-12</pub-id><pub-id pub-id-type="pmid">21933410</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>JW</given-names></name><name><surname>Park</surname> <given-names>YH</given-names></name><name><surname>Seok</surname> <given-names>YJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Rsd balances (p)ppGpp level by stimulating the hydrolase activity of SpoT during carbon source downshift in <italic>Escherichia coli</italic></article-title><source>PNAS</source><volume>115</volume><fpage>E6845</fpage><lpage>E6854</lpage><pub-id pub-id-type="doi">10.1073/pnas.1722514115</pub-id><pub-id pub-id-type="pmid">29915072</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>GW</given-names></name><name><surname>Burkhardt</surname> <given-names>D</given-names></name><name><surname>Gross</surname> <given-names>C</given-names></name><name><surname>Weissman</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Quantifying absolute protein synthesis rates reveals principles underlying allocation of cellular resources</article-title><source>Cell</source><volume>157</volume><fpage>624</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.02.033</pub-id><pub-id pub-id-type="pmid">24766808</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loveland</surname> <given-names>AB</given-names></name><name><surname>Bah</surname> <given-names>E</given-names></name><name><surname>Madireddy</surname> <given-names>R</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Brilot</surname> <given-names>AF</given-names></name><name><surname>Grigorieff</surname> <given-names>N</given-names></name><name><surname>Korostelev</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ribosome•RelA structures reveal the mechanism of stringent response activation</article-title><source>eLife</source><volume>5</volume><elocation-id>e17029</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.17029</pub-id><pub-id pub-id-type="pmid">27434674</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mechold</surname> <given-names>U</given-names></name><name><surname>Murphy</surname> <given-names>H</given-names></name><name><surname>Brown</surname> <given-names>L</given-names></name><name><surname>Cashel</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Intramolecular regulation of the opposing (p)ppGpp catalytic activities of Rel(Seq), the Rel/Spo enzyme from Streptococcus equisimilis</article-title><source>Journal of Bacteriology</source><volume>184</volume><fpage>2878</fpage><lpage>2888</lpage><pub-id pub-id-type="doi">10.1128/JB.184.11.2878-2888.2002</pub-id><pub-id pub-id-type="pmid">12003927</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metzger</surname> <given-names>S</given-names></name><name><surname>Sarubbi</surname> <given-names>E</given-names></name><name><surname>Glaser</surname> <given-names>G</given-names></name><name><surname>Cashel</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Protein sequences encoded by the relA and the spoT genes of <italic>Escherichia coli</italic> are interrelated</article-title><source>Journal of Biological Chemistry</source><volume>264</volume><fpage>9122</fpage><lpage>9125</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)60500-9</pub-id><pub-id pub-id-type="pmid">2542299</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="1972">1972</year><source>Experiments in Molecular Genetics</source><publisher-loc>Cold Spring Harbor, N.Y</publisher-loc><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name></element-citation></ref><ref id="bib37"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="1992">1992</year><source>A Short Course in Bacterial Genetics: A Laboratory Manual and Handbookfor Escherichia Coli and Related Bacteria</source><publisher-loc>Cold Spring Harbor, N.Y</publisher-loc><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>KD</given-names></name><name><surname>Bremer</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Control of spoT-dependent ppGpp synthesis and degradation in <italic>Escherichia coli</italic></article-title><source>Journal of Molecular Biology</source><volume>259</volume><fpage>41</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1006/jmbi.1996.0300</pub-id><pub-id pub-id-type="pmid">8648647</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neidhardt</surname> <given-names>FC</given-names></name><name><surname>Bloch</surname> <given-names>PL</given-names></name><name><surname>Smith</surname> <given-names>DF</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>Culture medium for enterobacteria</article-title><source>Journal of Bacteriology</source><volume>119</volume><fpage>736</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1128/jb.119.3.736-747.1974</pub-id><pub-id pub-id-type="pmid">4604283</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pausch</surname> <given-names>P</given-names></name><name><surname>Abdelshahid</surname> <given-names>M</given-names></name><name><surname>Steinchen</surname> <given-names>W</given-names></name><name><surname>Schäfer</surname> <given-names>H</given-names></name><name><surname>Gratani</surname> <given-names>FL</given-names></name><name><surname>Freibert</surname> <given-names>SA</given-names></name><name><surname>Wolz</surname> <given-names>C</given-names></name><name><surname>Turgay</surname> <given-names>K</given-names></name><name><surname>Wilson</surname> <given-names>DN</given-names></name><name><surname>Bange</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structural Basis for Regulation of the Opposing (p)ppGpp Synthetase and Hydrolase within the Stringent Response Orchestrator Rel</article-title><source>Cell Reports</source><volume>32</volume><elocation-id>108157</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108157</pub-id><pub-id pub-id-type="pmid">32937119</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peakman</surname> <given-names>T</given-names></name><name><surname>Crouzet</surname> <given-names>J</given-names></name><name><surname>Mayaux</surname> <given-names>JF</given-names></name><name><surname>Busby</surname> <given-names>S</given-names></name><name><surname>Mohan</surname> <given-names>S</given-names></name><name><surname>Harborne</surname> <given-names>N</given-names></name><name><surname>Wootton</surname> <given-names>J</given-names></name><name><surname>Nicolson</surname> <given-names>R</given-names></name><name><surname>Cole</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1990">1990a</year><article-title>Nucleotide sequence, organisation and structural analysis of the products of genes in the nirB-cysG region of the <italic>Escherichia coli</italic> K-12 chromosome</article-title><source>European Journal of Biochemistry</source><volume>191</volume><fpage>315</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1111/j.1432-1033.1990.tb19125.x</pub-id><pub-id pub-id-type="pmid">2200672</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peakman</surname> <given-names>T</given-names></name><name><surname>Busby</surname> <given-names>S</given-names></name><name><surname>Cole</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1990">1990b</year><article-title>Transcriptional control of the cysG gene of <italic>Escherichia coli</italic> K-12 during aerobic and anaerobic growth</article-title><source>European Journal of Biochemistry</source><volume>191</volume><fpage>325</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1111/j.1432-1033.1990.tb19126.x</pub-id><pub-id pub-id-type="pmid">2200673</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname> <given-names>FS</given-names></name><name><surname>Kjeldgaard</surname> <given-names>NO</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Analysis of the relA gene product of <italic>Escherichia coli</italic></article-title><source>European Journal of Biochemistry</source><volume>76</volume><fpage>91</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1111/j.1432-1033.1977.tb11573.x</pub-id><pub-id pub-id-type="pmid">195816</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname> <given-names>BN</given-names></name><name><surname>Young</surname> <given-names>MKM</given-names></name><name><surname>Luo</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Whiteley</surname> <given-names>AT</given-names></name><name><surname>Woodward</surname> <given-names>JJ</given-names></name><name><surname>Tong</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>JD</given-names></name><name><surname>Portnoy</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>(p)ppGpp and c-di-AMP Homeostasis Is Controlled by CbpB in Listeria monocytogenes</article-title><source>mBio</source><volume>11</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01625-20</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potrykus</surname> <given-names>K</given-names></name><name><surname>Cashel</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>(p)ppGpp: still magical?</article-title><source>Annual Review of Microbiology</source><volume>62</volume><fpage>35</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.62.081307.162903</pub-id><pub-id pub-id-type="pmid">18454629</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raskin</surname> <given-names>DM</given-names></name><name><surname>Judson</surname> <given-names>N</given-names></name><name><surname>Mekalanos</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Regulation of the stringent response is the essential function of the conserved bacterial G protein CgtA in <italic>Vibrio cholerae</italic></article-title><source>PNAS</source><volume>104</volume><fpage>4636</fpage><lpage>4641</lpage><pub-id pub-id-type="doi">10.1073/pnas.0611650104</pub-id><pub-id pub-id-type="pmid">17360576</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronneau</surname> <given-names>S</given-names></name><name><surname>Petit</surname> <given-names>K</given-names></name><name><surname>De Bolle</surname> <given-names>X</given-names></name><name><surname>Hallez</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Phosphotransferase-dependent accumulation of (p)ppGpp in response to glutamine deprivation in Caulobacter crescentus</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11423</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11423</pub-id><pub-id pub-id-type="pmid">27109061</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronneau</surname> <given-names>S</given-names></name><name><surname>Caballero-Montes</surname> <given-names>J</given-names></name><name><surname>Coppine</surname> <given-names>J</given-names></name><name><surname>Mayard</surname> <given-names>A</given-names></name><name><surname>Garcia-Pino</surname> <given-names>A</given-names></name><name><surname>Hallez</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Regulation of (p)ppGpp hydrolysis by a conserved archetypal regulatory domain</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>843</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1201</pub-id><pub-id pub-id-type="pmid">30496454</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronneau</surname> <given-names>S</given-names></name><name><surname>Hallez</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Make and break the alarmone: regulation of (p)ppGpp synthetase/hydrolase enzymes in bacteria</article-title><source>FEMS Microbiology Reviews</source><volume>43</volume><fpage>389</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1093/femsre/fuz009</pub-id><pub-id pub-id-type="pmid">30980074</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname> <given-names>W</given-names></name><name><surname>Vrentas</surname> <given-names>CE</given-names></name><name><surname>Sanchez-Vazquez</surname> <given-names>P</given-names></name><name><surname>Gaal</surname> <given-names>T</given-names></name><name><surname>Gourse</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The magic spot: a ppGpp binding site on <italic>E. coli</italic> RNA polymerase responsible for regulation of transcription initiation</article-title><source>Molecular Cell</source><volume>50</volume><fpage>420</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.03.021</pub-id><pub-id pub-id-type="pmid">23623682</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname> <given-names>W</given-names></name><name><surname>Sanchez-Vazquez</surname> <given-names>P</given-names></name><name><surname>Chen</surname> <given-names>AY</given-names></name><name><surname>Lee</surname> <given-names>JH</given-names></name><name><surname>Burgos</surname> <given-names>HL</given-names></name><name><surname>Gourse</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>ppGpp Binding to a Site at the RNAP-DksA Interface Accounts for Its Dramatic Effects on Transcription Initiation during the Stringent Response</article-title><source>Molecular Cell</source><volume>62</volume><fpage>811</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.04.029</pub-id><pub-id pub-id-type="pmid">27237053</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Vazquez</surname> <given-names>P</given-names></name><name><surname>Dewey</surname> <given-names>CN</given-names></name><name><surname>Kitten</surname> <given-names>N</given-names></name><name><surname>Ross</surname> <given-names>W</given-names></name><name><surname>Gourse</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genome-wide effects on <italic>Escherichia coli</italic> transcription from ppGpp binding to its two sites on RNA polymerase</article-title><source>PNAS</source><volume>116</volume><fpage>8310</fpage><lpage>8319</lpage><pub-id pub-id-type="doi">10.1073/pnas.1819682116</pub-id><pub-id pub-id-type="pmid">30971496</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanyal</surname> <given-names>R</given-names></name><name><surname>Harinarayanan</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Activation of RelA by pppGpp as the basis for its differential toxicity over ppGpp in <italic>Escherichia coli</italic></article-title><source>Journal of Biosciences</source><volume>45</volume><elocation-id>2</elocation-id><pub-id pub-id-type="doi">10.1007/s12038-020-9991-2</pub-id><pub-id pub-id-type="pmid">32020910</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname> <given-names>G</given-names></name><name><surname>Metzger</surname> <given-names>S</given-names></name><name><surname>Aizenman</surname> <given-names>E</given-names></name><name><surname>Roza</surname> <given-names>S</given-names></name><name><surname>Cashel</surname> <given-names>M</given-names></name><name><surname>Glaser</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Overexpression of the relA gene in <italic>Escherichia coli</italic></article-title><source>Journal of Biological Chemistry</source><volume>266</volume><fpage>3760</fpage><lpage>3767</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(19)67860-9</pub-id><pub-id pub-id-type="pmid">1899866</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seyfzadeh</surname> <given-names>M</given-names></name><name><surname>Keener</surname> <given-names>J</given-names></name><name><surname>Nomura</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>spoT-dependent accumulation of guanosine tetraphosphate in response to fatty acid starvation in <italic>Escherichia coli</italic></article-title><source>PNAS</source><volume>90</volume><fpage>11004</fpage><lpage>11008</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.23.11004</pub-id><pub-id pub-id-type="pmid">7504290</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname> <given-names>AK</given-names></name><name><surname>Winther</surname> <given-names>KS</given-names></name><name><surname>Roghanian</surname> <given-names>M</given-names></name><name><surname>Gerdes</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fatty acid starvation activates RelA by depleting lysine precursor pyruvate</article-title><source>Molecular Microbiology</source><volume>112</volume><fpage>1339</fpage><lpage>1349</lpage><pub-id pub-id-type="doi">10.1111/mmi.14366</pub-id><pub-id pub-id-type="pmid">31400173</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spira</surname> <given-names>B</given-names></name><name><surname>Silberstein</surname> <given-names>N</given-names></name><name><surname>Yagil</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Guanosine 3',5'-bispyrophosphate (ppGpp) synthesis in cells of <italic>Escherichia coli</italic> starved for Pi</article-title><source>Journal of Bacteriology</source><volume>177</volume><fpage>4053</fpage><lpage>4058</lpage><pub-id pub-id-type="doi">10.1128/jb.177.14.4053-4058.1995</pub-id><pub-id pub-id-type="pmid">7608079</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname> <given-names>H</given-names></name><name><surname>Roghanian</surname> <given-names>M</given-names></name><name><surname>Murina</surname> <given-names>V</given-names></name><name><surname>Dzhygyr</surname> <given-names>I</given-names></name><name><surname>Murayama</surname> <given-names>R</given-names></name><name><surname>Akanuma</surname> <given-names>G</given-names></name><name><surname>Atkinson</surname> <given-names>GC</given-names></name><name><surname>Garcia-Pino</surname> <given-names>A</given-names></name><name><surname>Hauryliuk</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The C-Terminal RRM/ACT Domain Is Crucial for Fine-Tuning the Activation of 'Long' RelA-SpoT Homolog Enzymes by Ribosomal Complexes</article-title><source>Frontiers in Microbiology</source><volume>11</volume><elocation-id>277</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.00277</pub-id><pub-id pub-id-type="pmid">32184768</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamman</surname> <given-names>H</given-names></name><name><surname>Van Nerom</surname> <given-names>K</given-names></name><name><surname>Takada</surname> <given-names>H</given-names></name><name><surname>Vandenberk</surname> <given-names>N</given-names></name><name><surname>Scholl</surname> <given-names>D</given-names></name><name><surname>Polikanov</surname> <given-names>Y</given-names></name><name><surname>Hofkens</surname> <given-names>J</given-names></name><name><surname>Talavera</surname> <given-names>A</given-names></name><name><surname>Hauryliuk</surname> <given-names>V</given-names></name><name><surname>Hendrix</surname> <given-names>J</given-names></name><name><surname>Garcia-Pino</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A nucleotide-switch mechanism mediates opposing catalytic activities of Rel enzymes</article-title><source>Nature Chemical Biology</source><volume>16</volume><fpage>834</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1038/s41589-020-0520-2</pub-id><pub-id pub-id-type="pmid">32393900</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traxler</surname> <given-names>MF</given-names></name><name><surname>Summers</surname> <given-names>SM</given-names></name><name><surname>Nguyen</surname> <given-names>HT</given-names></name><name><surname>Zacharia</surname> <given-names>VM</given-names></name><name><surname>Hightower</surname> <given-names>GA</given-names></name><name><surname>Smith</surname> <given-names>JT</given-names></name><name><surname>Conway</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The global, ppGpp-mediated stringent response to amino acid starvation in <italic>Escherichia coli</italic></article-title><source>Molecular Microbiology</source><volume>68</volume><fpage>1128</fpage><lpage>1148</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06229.x</pub-id><pub-id pub-id-type="pmid">18430135</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turnbull</surname> <given-names>KJ</given-names></name><name><surname>Dzhygyr</surname> <given-names>I</given-names></name><name><surname>Lindemose</surname> <given-names>S</given-names></name><name><surname>Hauryliuk</surname> <given-names>V</given-names></name><name><surname>Roghanian</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Intramolecular Interactions Dominate the Autoregulation of <italic>Escherichia coli</italic> Stringent Factor RelA</article-title><source>Frontiers in Microbiology</source><volume>10</volume><elocation-id>1966</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2019.01966</pub-id><pub-id pub-id-type="pmid">31507571</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyson</surname> <given-names>K</given-names></name><name><surname>Busby</surname> <given-names>S</given-names></name><name><surname>Cole</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Catabolite regulation of two <italic>Escherichia coli</italic> operons encoding nitrite reductases: role of the Cra protein</article-title><source>Archives of Microbiology</source><volume>168</volume><fpage>240</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1007/s002030050494</pub-id><pub-id pub-id-type="pmid">9382703</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uzan</surname> <given-names>M</given-names></name><name><surname>Danchin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>Correlation between the serine sensitivity and the derepressibility of the ilv genes in <italic>Escherichia coli</italic> relA- mutants</article-title><source>Molecular and General Genetics MGG</source><volume>165</volume><fpage>21</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1007/BF00270372</pub-id><pub-id pub-id-type="pmid">362163</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinella</surname> <given-names>D</given-names></name><name><surname>Albrecht</surname> <given-names>C</given-names></name><name><surname>Cashel</surname> <given-names>M</given-names></name><name><surname>D'Ari</surname> <given-names>R</given-names></name><name><surname>D’Ari</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Iron limitation induces SpoT-dependent accumulation of ppGpp in <italic>Escherichia coli</italic></article-title><source>Molecular Microbiology</source><volume>56</volume><fpage>958</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04601.x</pub-id><pub-id pub-id-type="pmid">15853883</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Dai</surname> <given-names>P</given-names></name><name><surname>Ding</surname> <given-names>D</given-names></name><name><surname>Del Rosario</surname> <given-names>A</given-names></name><name><surname>Grant</surname> <given-names>RA</given-names></name><name><surname>Pentelute</surname> <given-names>BL</given-names></name><name><surname>Laub</surname> <given-names>MT</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>Affinity-based capture and identification of protein effectors of the growth regulator ppGpp</article-title><source>Nature Chemical Biology</source><volume>15</volume><fpage>141</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1038/s41589-018-0183-4</pub-id><pub-id pub-id-type="pmid">30559427</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Tamiev</surname> <given-names>D</given-names></name><name><surname>Alagurajan</surname> <given-names>J</given-names></name><name><surname>DiSpirito</surname> <given-names>AA</given-names></name><name><surname>Phillips</surname> <given-names>GJ</given-names></name><name><surname>Hargrove</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>The role of the NADH-dependent nitrite reductase, Nir, from <italic>Escherichia coli</italic> in fermentative ammonification</article-title><source>Archives of Microbiology</source><volume>201</volume><fpage>519</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1007/s00203-018-1590-3</pub-id><pub-id pub-id-type="pmid">30406295</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Gunsalus</surname> <given-names>RP</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The nrfA and nirB nitrite reductase operons in <italic>Escherichia coli</italic> are expressed differently in response to nitrate than to nitrite</article-title><source>Journal of Bacteriology</source><volume>182</volume><fpage>5813</fpage><lpage>5822</lpage><pub-id pub-id-type="doi">10.1128/JB.182.20.5813-5822.2000</pub-id><pub-id pub-id-type="pmid">11004182</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wendrich</surname> <given-names>TM</given-names></name><name><surname>Blaha</surname> <given-names>G</given-names></name><name><surname>Wilson</surname> <given-names>DN</given-names></name><name><surname>Marahiel</surname> <given-names>MA</given-names></name><name><surname>Nierhaus</surname> <given-names>KH</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Dissection of the mechanism for the stringent factor RelA</article-title><source>Molecular Cell</source><volume>10</volume><fpage>779</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(02)00656-1</pub-id><pub-id pub-id-type="pmid">12419222</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wexselblatt</surname> <given-names>E</given-names></name><name><surname>Oppenheimer-Shaanan</surname> <given-names>Y</given-names></name><name><surname>Kaspy</surname> <given-names>I</given-names></name><name><surname>London</surname> <given-names>N</given-names></name><name><surname>Schueler-Furman</surname> <given-names>O</given-names></name><name><surname>Yavin</surname> <given-names>E</given-names></name><name><surname>Glaser</surname> <given-names>G</given-names></name><name><surname>Katzhendler</surname> <given-names>J</given-names></name><name><surname>Ben-Yehuda</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Relacin, a novel antibacterial agent targeting the Stringent Response</article-title><source>PLOS Pathogens</source><volume>8</volume><elocation-id>e1002925</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002925</pub-id><pub-id pub-id-type="pmid">23028324</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wexselblatt</surname> <given-names>E</given-names></name><name><surname>Kaspy</surname> <given-names>I</given-names></name><name><surname>Glaser</surname> <given-names>G</given-names></name><name><surname>Katzhendler</surname> <given-names>J</given-names></name><name><surname>Yavin</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Design, synthesis and structure-activity relationship of novel Relacin analogs as inhibitors of Rel proteins</article-title><source>European Journal of Medicinal Chemistry</source><volume>70</volume><fpage>497</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2013.10.036</pub-id><pub-id pub-id-type="pmid">24189495</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winther</surname> <given-names>KS</given-names></name><name><surname>Roghanian</surname> <given-names>M</given-names></name><name><surname>Gerdes</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Activation of the Stringent Response by Loading of RelA-tRNA Complexes at the Ribosomal A-Site</article-title><source>Molecular Cell</source><volume>70</volume><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.02.033</pub-id><pub-id pub-id-type="pmid">29625042</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wout</surname> <given-names>P</given-names></name><name><surname>Pu</surname> <given-names>K</given-names></name><name><surname>Sullivan</surname> <given-names>SM</given-names></name><name><surname>Reese</surname> <given-names>V</given-names></name><name><surname>Zhou</surname> <given-names>S</given-names></name><name><surname>Lin</surname> <given-names>B</given-names></name><name><surname>Maddock</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The <italic>Escherichia coli</italic> GTPase CgtAE cofractionates with the 50S ribosomal subunit and interacts with SpoT, a ppGpp synthetase/hydrolase</article-title><source>Journal of Bacteriology</source><volume>186</volume><fpage>5249</fpage><lpage>5257</lpage><pub-id pub-id-type="doi">10.1128/JB.186.16.5249-5257.2004</pub-id><pub-id pub-id-type="pmid">15292126</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>H</given-names></name><name><surname>Kalman</surname> <given-names>M</given-names></name><name><surname>Ikehara</surname> <given-names>K</given-names></name><name><surname>Zemel</surname> <given-names>S</given-names></name><name><surname>Glaser</surname> <given-names>G</given-names></name><name><surname>Cashel</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Residual guanosine 3',5'-bispyrophosphate synthetic activity of relA null mutants can be eliminated by spoT null mutations</article-title><source>Journal of Biological Chemistry</source><volume>266</volume><fpage>5980</fpage><lpage>5990</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(19)67694-5</pub-id><pub-id pub-id-type="pmid">2005134</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Ishiguro</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Dimerization of the RelA protein of <italic>Escherichia coli</italic></article-title><source>Biochemistry and Cell Biology</source><volume>79</volume><fpage>729</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1139/o01-144</pub-id><pub-id pub-id-type="pmid">11800013</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Zborníková</surname> <given-names>E</given-names></name><name><surname>Rejman</surname> <given-names>D</given-names></name><name><surname>Gerdes</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Novel (p)ppGpp binding and metabolizing proteins of <italic>Escherichia coli</italic></article-title><source>mBio</source><volume>9</volume><elocation-id>e02188-17</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.02188-17</pub-id><pub-id pub-id-type="pmid">29511080</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><boxed-text><table-wrap id="keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr valign="top"><th>Reagent type (species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr valign="top"><td>strain, strain background (<italic>Escherichia coli</italic>)</td><td>BTH101</td><td><xref ref-type="bibr" rid="bib25">Karimova et al., 1998</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.95.10.5752">10.1073/pnas.95.10.5752</ext-link></td><td/><td>F<sup>–</sup> <italic>cya-99 araD139 galE15 galK16 rpsL</italic>(<italic>Str</italic><sup><italic>R</italic></sup>) <italic>hsdR2 mcrA1 mcrB1 relA1</italic></td></tr><tr valign="top"><td>strain, strain background (<italic>E. coli</italic>)</td><td>BL21 (DE3)</td><td>New England Biolabs</td><td/><td>B F<sup>–</sup> <italic>ompT gal</italic></td></tr><tr valign="top"><td>strain, strain background (<italic>E. coli</italic>)</td><td>MG1655; WT</td><td>Lab collection</td><td/><td>Wild-type</td></tr><tr valign="top"><td>strain, strain background (<italic>E. coli</italic>)</td><td><italic>nirD</italic><sup><italic>E50K</italic></sup></td><td>This paper</td><td/><td>MG1655 <italic>nirD</italic><sup><italic>E50K</italic></sup></td></tr><tr valign="top"><td>strain, strain background (<italic>E. coli</italic>)</td><td>Δ<italic>nirD</italic></td><td>This paper</td><td/><td>MG1655 <italic>nirD::FRT</italic>; P1 from KEIO collection (resistance cassette has been flipped out) (<xref ref-type="bibr" rid="bib3">Baba et al., 2006</xref>)</td></tr><tr valign="top"><td>strain, strain background (<italic>E. coli</italic>)</td><td>Δ<italic>relA</italic></td><td><xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-019-13764-4">10.1038/s41467-019-13764-4</ext-link></td><td/><td>MG1655 <italic>relA::FRT</italic></td></tr><tr valign="top"><td>strain, strain background (<italic>E. coli</italic>)</td><td>Δ<italic>relA spoT</italic></td><td>This paper</td><td/><td>MG1655 relA::FRT spoT207::cat; P1 transduction from CF1693 (<xref ref-type="bibr" rid="bib3">Baba et al., 2006</xref>) in MG1655 <italic>relA::FRT</italic></td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pBbS2k-<italic>rfp</italic></td><td><xref ref-type="bibr" rid="bib30">Lee et al., 2011</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1754-1611-5-12">10.1186/1754-1611-5-12</ext-link></td><td/><td>Kan<sup>R</sup>, P<sub>tet</sub>, <italic>rfp</italic></td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pBbS2k-<italic>relA</italic></td><td>This paper</td><td/><td>Kan<sup>R</sup>, P<sub>tet</sub>, <italic>relA</italic>; primers 16/17; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pBbS2k-<italic>relA</italic> (sd4)</td><td>This paper</td><td/><td>Kan<sup>R</sup>, P<sub>tet</sub>, sd4, <italic>relA</italic>; primers 163/17; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pBbS2k-<italic>relA</italic><sup><italic>N-terminal</italic></sup></td><td>This paper</td><td/><td>Kan<sup>R</sup>, P<sub>tet</sub>, <italic>relA</italic><sup><italic>N-terminal</italic></sup>; primers 16/557; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pEG25</td><td><xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-019-13764-4">10.1038/s41467-019-13764-4</ext-link></td><td/><td>Amp<sup>R</sup>, P<sub>T5-lac</sub></td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pEG25-<italic>nirD</italic></td><td>This paper</td><td/><td>Amp<sup>R</sup>, P<sub>T5-lac</sub>, <italic>nirD</italic>; primers 386/387; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pEG25-<italic>spoT</italic> (sd8U)</td><td><xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-019-13764-4">10.1038/s41467-019-13764-4</ext-link></td><td/><td>Amp<sup>R</sup>, P<sub>T5-lac</sub>, sd8U, <italic>spoT</italic></td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pEG25-<italic>nirD</italic><sup><italic>E50K</italic></sup></td><td>This paper</td><td/><td>Amp<sup>R</sup>, P<sub>T5-lac</sub>, <italic>nirD</italic><sup><italic>E50K</italic></sup>; primers 386/387; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pEG25-<italic>nirD</italic> (WTsd)</td><td>This paper</td><td/><td>Amp<sup>R</sup>, P<sub>T5-lac</sub>, WTsd, <italic>nirD</italic>; primers 555/387; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pEG25-<italic>nirBD</italic> (WTsd)</td><td>This paper</td><td/><td>Amp<sup>R</sup>, P<sub>T5-lac</sub>, WTsd, <italic>nirBD</italic>; primers 553/544; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pEG25-<italic>relA</italic><sup><italic>N-terminal</italic></sup></td><td><xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-019-13764-4">10.1038/s41467-019-13764-4</ext-link></td><td/><td>Amp<sup>R</sup>, P<sub>T5-lac</sub>, <italic>relA</italic><sup><italic>N-terminal</italic></sup></td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pKD46</td><td><xref ref-type="bibr" rid="bib11">Datsenko and Wanner, 2000</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.120163297">10.1073/pnas.120163297</ext-link></td><td/><td>Amp<sup>R</sup>, P<sub>ara</sub>, λ Red</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pKT25</td><td><xref ref-type="bibr" rid="bib25">Karimova et al., 1998</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.95.10.5752">10.1073/pnas.95.10.5752</ext-link></td><td/><td>Kan<sup>R</sup></td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pKT25-<italic>zip</italic></td><td><xref ref-type="bibr" rid="bib25">Karimova et al., 1998</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.95.10.5752">10.1073/pnas.95.10.5752</ext-link></td><td/><td>Kan<sup>R</sup>, <italic>zip</italic></td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pKT25-<italic>relA</italic></td><td><xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-019-13764-4">10.1038/s41467-019-13764-4</ext-link></td><td/><td>Kan<sup>R</sup>, <italic>relA</italic></td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pKT25-<italic>spoT</italic></td><td><xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-019-13764-4">10.1038/s41467-019-13764-4</ext-link></td><td/><td>Kan<sup>R</sup>, <italic>spoT</italic></td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pKT25-<italic>nirB</italic></td><td>This paper</td><td/><td>Kan<sup>R</sup>, <italic>nirB</italic>; primers 617/618; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pKT25-<italic>relA</italic><sup><italic>1-663</italic></sup></td><td>This paper</td><td/><td>Kan<sup>R</sup>, <italic>relA</italic><sup><italic>1-663</italic></sup>; primers 497/502; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pKT25-<italic>relA</italic><sup><italic>1-580</italic></sup></td><td>This paper</td><td/><td>Kan<sup>R</sup>, <italic>relA</italic><sup><italic>1-580</italic></sup>; primers 497/501; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pKT25-<italic>relA</italic><sup><italic>1-470</italic></sup></td><td>This paper</td><td/><td>Kan<sup>R</sup>, <italic>relA</italic><sup><italic>1-470</italic></sup>; primers 497/500; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pKT25-<italic>relA</italic><sup><italic>N-terminal</italic></sup></td><td>This paper</td><td/><td>Kan<sup>R</sup>, <italic>relA</italic><sup><italic>N-terminal</italic></sup>; primers 497/499; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pKT25-<italic>relA</italic><sup><italic>1-181</italic></sup></td><td>This paper</td><td/><td>Kan<sup>R</sup>, <italic>relA</italic><sup><italic>1-181</italic></sup>; primers 497/498; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pKT25-<italic>relA</italic><sup><italic>181-744</italic></sup></td><td>This paper</td><td/><td>Kan<sup>R</sup>, <italic>relA</italic><sup><italic>181-744</italic></sup>; primers 531/533; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pKT25-<italic>spoT</italic><sup><italic>N-terminal</italic></sup></td><td><xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-019-13764-4">10.1038/s41467-019-13764-4</ext-link></td><td/><td>Kan<sup>R</sup>, <italic>relA</italic><sup><italic>N-terminal</italic></sup></td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pUT18C</td><td><xref ref-type="bibr" rid="bib25">Karimova et al., 1998</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.95.10.5752">10.1073/pnas.95.10.5752</ext-link></td><td/><td>Amp<sup>R</sup></td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pUT18C-<italic>zip</italic></td><td><xref ref-type="bibr" rid="bib25">Karimova et al., 1998</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.95.10.5752">10.1073/pnas.95.10.5752</ext-link></td><td/><td>Amp<sup>R</sup>, <italic>zip</italic></td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pUT18C-<italic>nirD</italic></td><td>This paper</td><td/><td>Amp<sup>R</sup>, <italic>nirD</italic>; primers 441/443; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pUT18C-<italic>nirD</italic><sup><italic>E50K</italic></sup></td><td>This paper</td><td/><td>Amp<sup>R</sup>, <italic>nirD</italic><sup><italic>E50K</italic></sup>; primers 441/443; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pET28a(+)</td><td><xref ref-type="bibr" rid="bib13">Germain et al., 2019</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-019-13764-4">10.1038/s41467-019-13764-4</ext-link></td><td/><td>Kan<sup>R</sup>, Trx, His</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pET28a(+)-<italic>nirD</italic></td><td>This paper</td><td/><td>Kan<sup>R</sup>, Trx, His, TEV, <italic>nirD</italic>; primers 558/544; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pET28a(+)-<italic>nirD</italic><sup><italic>E50K</italic></sup></td><td>This paper</td><td/><td>Kan<sup>R</sup>, Trx, His, TEV, <italic>nirD</italic><sup><italic>E50K</italic></sup>; primers 558/544; Maisonneuve lab</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pWRG99</td><td><xref ref-type="bibr" rid="bib5">Blank et al., 2011</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0015763">10.1371/journal.pone.0015763</ext-link></td><td/><td>pKD46 with Ptet, I-SceI</td></tr><tr valign="top"><td>recombinant DNA reagent</td><td>pWRG100</td><td><break/><xref ref-type="bibr" rid="bib25">Karimova et al., 1998</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.95.10.5752">10.1073/pnas.95.10.5752</ext-link> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0015763">10.1371/journal.pone.0015763</ext-link></td><td/><td>pKD3 with I-<italic>Sce</italic>I recognition site</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 16</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGAATTCGTCGACTCAAGGAGGTTTTATAAATGGTTGCGGTAAGAAGTGCA</named-content>; restriction enzyme EcoRI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 17</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGGATCCCTAACTCCCGTGCAACCGAC</named-content>; restriction enzyme BamHI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 163</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGAATTCGTCGACTCAAGGATTAAATGGTTGCGGTAAGAAGTGCA</named-content>; restriction enzyme EcoRI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 386</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGAATTCGTCGACTCAAGGAGGTTTTATAAATGAGCCAGTGGAAAGACAT</named-content>; restriction enzyme EcoRI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 387</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGGATCCTTAACCGCGCAGCTGCACCA</named-content>; restriction enzyme BamHI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 441</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCTCTAGAAATGAGCCAGTGGAAAGACAT</named-content>; restriction enzyme XbaI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 443</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGGTACCTTAACCGCGCAGCTGCACCA</named-content>; restriction enzyme KpnI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 497</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCTCTAGAAATGGTTGCGGTAAGAAGTGC</named-content>; restriction enzyme XbaI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 498</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGGTACCGATGTTGGTACACTCTTTTG</named-content>; restriction enzyme KpnI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 499</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGGTACCTTCGTCGAGCATTTCGCCGG</named-content>; restriction enzyme KpnI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 500</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGGTACCGTTCGGCTGTTTCTGGGTGA</named-content>; restriction enzyme KpnI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 501</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGGTACCAAGTTGCTTCAGCGCGGCGG</named-content>; restriction enzyme KpnI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 502</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGGTACCGGCGGAGTAGCTCTCACCCC</named-content>; restriction enzyme KpnI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 531</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCTCTAGAATACGCACCGCTGGCTAACCG</named-content>; restriction enzyme XbaI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 533</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGGTACCCTAACTCCCGTGCAACCGAC</named-content>; restriction enzyme KpnI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 544</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCAAGCTTTTAACCGCGCAGCTGCACCA</named-content>; restriction enzyme HindIII; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 553</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGAATTCAATAGAAAAGAAATCGAGGCAAAAATGAGCAAAGTCAGACTCGC</named-content>; restriction enzyme EcoRI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 555</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGAATTCAGTAACTCTGGTGGAGGACAACGCATGAGCCAGTGGAAAGACAT</named-content>; restriction enzyme EcoRI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 557</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGGATCCTTATTCGTCGAGCATTTCGCCGG</named-content>; restriction enzyme BamHI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 558</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGGATCCGAGAACCTGTACTTCCAATCAATGAGCCAGTGGAAAGACAT</named-content>; restriction enzyme BamHI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 617</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCTCTAGAAATGAGCAAAGTCAGACTCGC</named-content>; restriction enzyme XbaI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 618</td><td>This paper</td><td/><td><named-content content-type="sequence">CCCCGGTACCTCATGCGTTGTCCTCCACCA</named-content>; restriction enzyme KpnI; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 629</td><td>This paper</td><td/><td><named-content content-type="sequence">ATGAGCCAGTGGAAAGACATCTGCAAAATCGATGACATCCTGCCTGAAACCGCCTTACGCCCCGCCCTGC</named-content>; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 630</td><td>This paper</td><td/><td><named-content content-type="sequence">TTAACCGCGCAGCTGCACCACGCCGTCTTTCACTCGCGCTTCGTAATGTTCTAGACTATATTACCCTGTT</named-content>; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 655</td><td>This paper</td><td/><td><named-content content-type="sequence">ATGAGCCAGTGGAAAGACAT</named-content>; Maisonneuve lab</td></tr><tr valign="top"><td>sequence-based reagent</td><td>Primer 656</td><td>This paper</td><td/><td><named-content content-type="sequence">TTAACCGCGCAGCTGCACCA</named-content>; Maisonneuve lab</td></tr><tr valign="top"><td>chemical compound, drug</td><td>[α<sup>32</sup>P]GTP</td><td>PerkinElmer</td><td>Catalog number: BLU006H250UC</td><td/></tr><tr valign="top"><td>chemical compound, drug</td><td><sup>32</sup>P</td><td>PerkinElmer</td><td>Catalog number: NEX053H001MC</td><td/></tr><tr valign="top"><td>chemical compound, drug</td><td>EZ-Link NHS-PEG4-Biotin</td><td>Thermo Scientific</td><td>Catalog number: 21330</td><td/></tr><tr valign="top"><td>software, algorithm</td><td>BLItz Pro Software</td><td/><td><ext-link ext-link-type="uri" xlink:href="https://www.sartorius.com/en/products/protein-analysis">https://www.sartorius.com/en/products/protein-analysis</ext-link></td><td/></tr><tr valign="top"><td>software, algorithm</td><td>MicroCal PEAQ-ITC Analysis Software</td><td>Malvern Panalytical</td><td><ext-link ext-link-type="uri" xlink:href="https://www.malvernpanalytical.com/fr/products/product-range/microcal-range/microcal-itc-range/microcal-peaq-itc">https://www.malvernpanalytical.com/fr/products/product-range/microcal-range/microcal-itc-range/microcal-peaq-itc</ext-link></td><td/></tr><tr valign="top"><td>software, algorithm</td><td>Prism 5.0 software</td><td>GraphPad</td><td><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/scientific-software/prism/">https://www.graphpad.com/scientific-software/prism/</ext-link></td><td/></tr><tr valign="top"><td>other</td><td>HiLoad 16/600 Superdex 200 column</td><td>GE Healthcare</td><td>Catalog number: GE28-9893-35</td><td/></tr><tr valign="top"><td>other</td><td>HiPrep 26/10 Desalting column</td><td>GE Healthcare</td><td>Catalog number: GE17-5087-01</td><td/></tr><tr valign="top"><td>other</td><td>HisTrap column</td><td>GE Healthcare</td><td>Catalog number: GE17-5248-02</td><td/></tr><tr valign="top"><td>other</td><td>Streptavidin Biosensors</td><td>FortéBio</td><td>Catalog number: 18-5117</td><td/></tr><tr valign="top"><td>other</td><td>Superdex 200 10/300 GL</td><td>GE Healthcare</td><td>Catalog number: GE28-9909-44</td><td/></tr><tr valign="top"><td>other</td><td>Zeba Spin Desalting column</td><td>Thermo Scientific</td><td>Catalog number: 89882</td><td/></tr></tbody></table></table-wrap></boxed-text></app></app-group></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.64092.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Helaine</surname><given-names>Sophie</given-names></name><role>Reviewing Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Ronneau</surname><given-names>Severin</given-names> </name><role>Reviewer</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>The reviewers all agreed that the work is very interesting and intriguing and potentially of great interest as you report the identification of NirD, the small subunit of a nitrite reductase, as a new negative regulator of the stringent response in <italic>E. coli</italic>. Seeing the importance of the stringent response in bacterial adaptation to environmental stresses, it is potentially a significant advance.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;NirD Curtails the Stringent Response by Inhibiting RelA Activity in <italic>Escherichia coli</italic>&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 4 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Gisela Storz as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Severin Ronneau (Reviewer #1).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at eLife&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>The reviewers all agreed that the work is very interesting and intriguing and potentially of great interest as you report through a multicopy suppressor screen the identification of NirD, the small subunit of a nitrite reductase, as a new negative regulator of the stringent response in <italic>E. coli</italic>. Seeing the importance of the stringent response in bacterial adaptation to environmental stresses, it is potentially a significant advance. Specifically, overexpression of NirD very convincingly inhibits RelA-dependent production of (p)ppGpp, NirD interacts with the N-terminal domain of RelA, both in vitro and in <italic>E. coli</italic>, leading to reduction of (p)ppGpp synthesis.</p><p>However, all reviewers were in agreement that additional work is needed to establish the physiological relevance of this regulation. Although solid and well controlled, all the experiments rely on overexpression of NirD. Reviewers reckon that evidence of the importance of the interaction between NirD and RelA through phenotypic and molecular characterizations of null and point mutants is required before we can accept the manuscript for publication. They have agreed on a minimal set of experiments that are essential if you chose to revise the manuscript. In addition, they were also all of the opinion that the text should be revised to reflect the most up-to-date and relevant literature, and add depth to the discussion. Their main requests are the following:</p><p>Essential revisions:</p><p>– Measure levels of (p)ppGpp in wild-type <italic>E. coli</italic>, nirD, nirD_E50K, nirB and nirBD mutants in aa starvation, stationary phase, aerobic and anaerobic growth.</p><p>– Report the effects of nirD or nirBD mutations on growth under the above environmental conditions.</p><p>– Document the ratio of RelA:NirD. Is RelA in a much higher abundance than NirD? How does this relate to the importance of the interaction?</p><p>– Revise the text according to the following remarks:</p><p>a – Page 3, lines 12-17: with reference to the targets and roles of (p)ppGpp, the authors cite Atkinson et al., 2011; Kanjee et al. 2012; Hauryliuk et al. 2015 and Potrykus and Cashel 2008.</p><p>Remove here the reference of Atkinson et al., 2011, which described the phylogenic distribution of RSH enzymes.</p><p>– Add to or replace Kanjee et al. 2012 more recent papers in which they identified (p)ppGpp targets: Corrigan et al., 2016 (PMID: 26951678); Zhang et al., 2018 (PMID: 29511080); Wang et al., 2019 (PMID: 30559427)</p><p>– Add to or replace Hauryliuk et al. 2015 and Potrykus and Cashel 2008 by updated reviews: Hengge 2020 (PMID: 32244175); Irving et al. 2020 (PMID: 33149273)</p><p>b – Page 3, Line 23: in relation to the CTD, references Pausch 2020 Cell Reports, Takada 2020 Front Microbiol, and Gratani 2018 Plos Genetics should be included.</p><p>c – When describing RelA and SpoT as well as the mechanisms regulating their activities, the authors refer to only two research papers (Hogg et al., 2004; Mechold et al., 2002) and again the same reviews (Hauryliuk et al., 2015; Potrykus and Cashel 2008). Add Tamman et al., 2020 (PMID: 32393900)</p><p>d – Page 4, Line 4: two recent reviews extensively describe how stress signals are sensed by RSH enzymes. In place of Potrykus and Cashel, 2008, cite these:</p><p>Irving SE, Corrigan RM. (PMID: 29493495); Ronneau S, Hallez R. (PMID: 30980074)</p><p>e – Page 4, line 24, remove the &quot;in&quot; after Rsd.</p><p>f – Page 4: It would be interesting to add that RelA can also be activated by other stressful conditions than aa starvation which ultimately leads to aa starvation, e.g. fatty acid starvation that leads to lysine starvation (Sinha et al., 2019, PMID: 31400173).</p><p>g – Comment on why GppA relieves toxicity? pppGpp is less toxic than ppGpp, why?</p><p>h – Page 8, line 20 and page 13, line 9: add reports describing RSH regulation by</p><p>– the competence proteins ComGA: Hahn et al., 2015 (PMC4722805)</p><p>– the phosphotransferase system: Karstens et al., 2014 (PMID: 24515609); Ronneau et al., 2016 (PMID: 27109061); Ronneau et al., 2019 (PMID: 30496454).</p><p>i – Page 8, line 3, &quot;zing&quot; correct the typo.</p><p>j – Page 11, line7 – change to S5B and C to S4B and C. Also include A-E labels in figure S4 and a specific legend for S4E.</p><p>k – Page 19 line 15 – change broh to broth.</p><p>l – What do you mean by &quot;ribosome-independent inhibition of the stringent response&quot;?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.64092.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>– Measure levels of (p)ppGpp in wild-type E. coli, nirD, nirD_E50K, nirB and nirBD mutants in aa starvation, stationary phase, aerobic and anaerobic growth.</p></disp-quote><p>We measured (p)ppGpp level of wild-type (WT), ΔnirD, and ΔrelA mutants during aerobic amino acid starvation and stationary phase entry (when (p)ppGpp rised). As shown, no significant difference is observed between WT and ΔnirD. These results are not unexpected given that nirD is not induced under these growth conditions. Indeed, nirD is induced during anaerobic growth (Harborne et al., 1992; Peakman et al., 1990) and its expression is maximized in the presence of glucose and nitrate (Tyson et al., 1997; Wang and Gunsalus, 2000).</p><p>For amino acid starvation (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>, left panel), exponentially growing cells of WT, ΔnirD, and ΔrelA were challenged by addition of 500 μg/mL of L-valine. Nucleotides were extracted from samples collected at the indicated times and separated by TLC. The autoradiogram is representative of 3 independent experiments. For measurement of stationary phase (p)ppGpp levels (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>, right panel), exponentially growing cells of WT, ΔnirD, and ΔrelA were labeled at OD600nm ~0.25 and samples were collected from 3 hours later, at the entrance into stationary phase. Nucleotides were extracted and separated by TLC. The autoradiogram is representative of 3 independent experiments.</p><fig id="sa2fig1"><label>Author response image 1.</label><caption><title><italic>nirD</italic> does not seem to impact accumulation of (p)ppGpp during amino acid starvation or in stationary phase under aerobic conditions.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64092-resp-fig1-v1.tif"/></fig><p>Unfortunately, with respect to safety rules, we were technically not able to address this question during anaerobic growth conditions. Indeed, rules regarding the use of radioelements are strictly controlled and experiments have to be performed in a restricted area which is not equipped with an anaerobic glove box. Moreover, experiments using hungate tubes are not tolerated since tubes are under pressure and required needles for sampling and finally would also require massive and unwarranted use of radioelements.</p><disp-quote content-type="editor-comment"><p>– Report the effects of nirD or nirBD mutations on growth under the above environmental conditions.</p></disp-quote><p>We first performed growth experiments in aerobic conditions and as shown, no significant difference is observed between WT and Δ<italic>nirD</italic> mutant. As explained above, <italic>nirD</italic> is maximally expressed in anaerobic growth conditions in presence of glucose and nitrate. Note also that the <italic>relA</italic> mutant does not display a significant phenotype under these conditions.</p><p>Growth curves of WT cells, ΔnirD and ΔrelA mutants under aerobic amino acid starvation (<xref ref-type="fig" rid="sa2fig2">Author response image 2</xref>, left panel) and stationary phase (<xref ref-type="fig" rid="sa2fig2">Author response image 2</xref>, right panel). Stationary-phase cultures were diluted 100 times in MOPS-glucose minimal medium. The cultures were then incubated at 37°C and growth was followed by measurement of OD600nm using microplate reader. To induce amino acid starvation, 500 μg/mL of L-valine was added at the indicated time. Data are represented as the means of 3 independent experiments, error bars depict the SDs.</p><fig id="sa2fig2"><label>Author response image 2.</label><caption><title><italic>nirD</italic> does not seem to affect growth during amino acid starvation or in stationary phase under aerobic conditions.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64092-resp-fig2-v1.tif"/></fig><p>As mentioned above, nirD is induced during anaerobic growth and its expression is maximized in the presence of glucose and nitrate. Moreover, the cytoplasmic nitrite reductase NirBD is a key regulator of the nitric oxide level during nitrate respiration and as a result a strain devoid of nitrite reductase activity presents a severe growth defect under nitrate respiration (Bulot et al., 2019). This led us to the conclusion that these conditions were not appropriated to dissociate the importance of NirD in the nitrite reductase activity to that of the regulation of RelA activity.</p><p>Therefore, to present evidence of a physiological relevance of the RelA-NirD in vivo, we decided to follow the growth of WT and ΔnirD mutant during anaerobic glucose fermentation, a condition where the nitrite reductase is expressed but where the substrate is missing. As shown in the new Figure 3E, no difference is observed between WT and ΔnirD mutant under unstressed conditions. However, addition of high concentrations of SMG (which induces isoleucine starvation) significantly increases the growth recovery of a ΔnirD mutant consistent with an elevated level of (p)ppGpp in this strain. To further confirm that the RelA-NirD interaction is important to adjust (p)ppGpp levels under these specific growth conditions, we have created a chromosomal nirDE50K mutant. We first confirmed that this mutant has a functional nitrite reductase activity. Indeed, the nirDE50K mutant grows similarly to the WT in presence of nitrate as sole nitrogen source (new Figure 3—figure supplement 1C). Finally, we observed that nirDE50K mutant displays the same growth defect recovery as the nirD mutant in presence of SMG.</p><p>Growth curves of WT cells, Δ<italic>nirD</italic> and <italic>nirDE50K</italic> mutants under anaerobiosis in M9-glucose minimal medium without amino acids (Figure 3E left panel) or supplemented with 1 mM serine, methionine, and glycine (SMG) (Figure 3E right panel) (see Materials and methods). The growth curves are representative of at least 3 independent experiments and the Δ(lag phase) are represented as the means (± SD) of the independent experiments.</p><p>Growth curves of WT cells, ΔnirD and nirDE50K mutants under anaerobiosis in defined glycerol minimal medium supplemented with nitrate as the sole electron acceptor and as sole nitrogen source (see Materials and methods and Figure 3—figure supplement 1C). Under nitrate respiration, nitrate is converted to nitrite which is subsequently converted to ammonium (NH4) by the cytosolic NADH-dependent nitrite reductase NirBD. Bacteria can then utilize NH4 as nitrogen source. Therefore, an active NADH-dependent nitrite reductase activity is required for anaerobic growth when nitrate is the sole nitrogen source (Wang et al., 2019).</p><p>Therefore, our results present physiological evidence that a specific RelA-NirD interaction can adjust (p)pGpp level in vivo.</p><p>A full paragraph explaining these new results is now provided in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>– Document the ratio of RelA:NirD. Is RelA in a much higher abundance than NirD? How does this relate to the importance of the interaction?</p></disp-quote><p>The equilibrium affinity constant (KD) of the RelA-NirD interaction obtained in vitro is around 300 nM and the concentration of RelA in <italic>E. coli</italic> is in the same range (100-400 nM) (Li et al., 2014; Pedersen and Kjeldgaard, 1977). Therefore, at the concentrations above the KD, NirD would interact with RelA and inhibit (p)ppGpp synthetase activity. Under aerobic conditions, NirD is not expressed and concentration is below 20 nM and regulation of RelA by NirD is probably meaningless. These results are consistent with the results presented above. However, under anaerobic growth conditions, NirD is predicted to reache μM range (Khlebodarova et al., 2016) and can therefore saturate RelA to catalytically inhibit its activity. These results are consistent with the observation that deletion of nirD in presence of RelA severely impaired growth recovery under anaerobic glucose fermentation conditions in presence of SMG.</p><p>The physiological relevance of the RelA-NirD interaction is now discussed in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>– Revise the text according to the following remarks:</p><p>a – Page 3, lines 12-17: with reference to the targets and roles of (p)ppGpp, the authors cite Atkinson et al., 2011; Kanjee et al. 2012; Hauryliuk et al. 2015 and Potrykus and Cashel 2008.</p><p>Remove here the reference of Atkinson et al., 2011, which described the phylogenic distribution of RSH enzymes.</p></disp-quote><p>We agree, the reference has been removed.</p><disp-quote content-type="editor-comment"><p>– Add to or replace Kanjee et al. 2012 more recent papers in which they identified (p)ppGpp targets: Corrigan et al., 2016 (PMID: 26951678); Zhang et al., 2018 (PMID: 29511080); Wang et al., 2019 (PMID: 30559427).</p><p>– Add to or replace Hauryliuk et al. 2015 and Potrykus and Cashel 2008 by updated reviews: Hengge 2020 (PMID: 32244175); Irving et al. 2020 (PMID: 33149273).</p></disp-quote><p>We thank the referees, changes have been made accordingly.</p><disp-quote content-type="editor-comment"><p>b – Page 3, Line 23: in relation to the CTD, references Pausch 2020 Cell Reports, Takada 2020 Front Microbiol, and Gratani 2018 Plos Genetics should be included.</p><p>c – When describing RelA and SpoT as well as the mechanisms regulating their activities, the authors refer to only two research papers (Hogg et al., 2004; Mechold et al., 2002) and again the same reviews (Hauryliuk et al., 2015; Potrykus and Cashel 2008). Add Tamman et al., 2020 (PMID: 32393900).</p></disp-quote><p>We apologize, changes have been made accordingly.</p><disp-quote content-type="editor-comment"><p>d – Page 4, Line 4: two recent reviews extensively describe how stress signals are sensed by RSH enzymes. In place of Potrykus and Cashel, 2008, cite these:</p><p>Irving SE, Corrigan RM. (PMID: 29493495); Ronneau S, Hallez R. (PMID: 30980074).</p></disp-quote><p>We agree, changes have been made accordingly.</p><disp-quote content-type="editor-comment"><p>e – Page 4, line 24, remove the &quot;in&quot; after Rsd.</p></disp-quote><p>We agree, the change has been made accordingly.</p><disp-quote content-type="editor-comment"><p>f – Page 4: It would be interesting to add that RelA can also be activated by other stressful conditions than aa starvation which ultimately leads to aa starvation, e.g. fatty acid starvation that leads to lysine starvation (Sinha et al., 2019, PMID: 31400173).</p></disp-quote><p>We agree, changes have been made accordingly.</p><disp-quote content-type="editor-comment"><p>g – Comment on why GppA relieves toxicity? pppGpp is less toxic than ppGpp, why?</p></disp-quote><p>Cited in the manuscript, Sanyal and Harinarayanan (2020) describe interesting in vivo findings regarding the pivotal role of SpoT and GppA hydrolase in lowering activation of RelA by the alarmone guanosine penta phosphate (pppGpp). Indeed, they present genetic evidence that pppGpp exerts heightened toxicity compare to that of ppGpp. The authors provide a simple model in which toxicity of pppGpp is mediated by its positive feedback activation of RelA (even in absence of activating signal) and thus setting up massive (p)ppGpp accumulation in <italic>E. coli</italic> cells. While the exact molecular mechanisms are not known, we believe that our observations that gppA reverts toxicity associated to (p)ppGpp accumulation are consistent with these findings.</p><p>Note also that early on, Kudrin et al. (2018) reported in vitro that RelA’s synthetic activity is adjusted by pppGpp, which stimulates synthesis of ppGpp from GDP to maximize (p)ppGpp accumulation.</p><disp-quote content-type="editor-comment"><p>h – Page 8, line 20 and page 13, line 9: add reports describing RSH regulation by</p><p>– the competence proteins ComGA: Hahn et al., 2015 (PMC4722805)</p><p>– the phosphotransferase system: Karstens et al., 2014 (PMID: 24515609); Ronneau et al., 2016 (PMID: 27109061); Ronneau et al., 2019 (PMID: 30496454).</p></disp-quote><p>The referee is correct, changes have been made accordingly.</p><disp-quote content-type="editor-comment"><p>i – Page 8, line 3, &quot;zing&quot; correct the typo.</p></disp-quote><p>We apologize, the change has been made.</p><disp-quote content-type="editor-comment"><p>j – Page 11, line7 – change to S5B and C to S4B and C. Also include A-E labels in figure S4 and a specific legend for S4E.</p></disp-quote><p>We apologize, changes have been made.</p><disp-quote content-type="editor-comment"><p>k – Page 19 line 15 – change broh to broth.</p></disp-quote><p>We apologize, the change has been made.</p><disp-quote content-type="editor-comment"><p>l – What do you mean by &quot;ribosome-independent inhibition of the stringent response&quot;?</p></disp-quote><p>NirD can inhibit the (p)ppGpp synthesis from the constitutively active truncated RelAN-terminal both in vivo and in vitro. Given that the CTD region is responsible for anchoring RelA to the ribosome and that ribosome is missing in our in vitro assay, our results support the notion that inactivation of RelA is possible even when the protein is not associated to the ribosome. Therefore, rather than preventing activation of RelA, our results support a simple model of regulation in which NirD directly interacts with the catalytic domains of RelA to inhibit the synthetic activity.</p></body></sub-article></article>